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Abstract
The use of iron oxide nanoparticles for a variety of applications has grown over the past
few decades. Manipulation of surface chemistry of these materials is critical to
customizing the properties of the particles for desired applications. Ligand exchange is a
common and versatile tool for surface modification. There are many factors which affect
ligand exchange including ligand chain length, number of binding groups, binding group
chemistry, and particle aging and oxidation. Furthermore, ligand exchange may not
always occur to completion. Therefore, it is important to characterize the surface of the
particles to determine the extent of exchange. Current techniques to confirm and monitor
ligand exchange can be limited in sensitivity and versatility, and often these techniques
must be used in combination to thoroughly characterize the exchange. To address this
issue, radioanalytical techniques were developed to quantify ligand exchange on iron
oxide nanoparticles and investigate the factors which affect ligand exchange. Oleic acid
coated iron oxide nanoparticles were synthesized via thermal decomposition with trace
amounts of 14C-oleic acid on the surface. The particles were modified via ligand
exchange with a variety of hydrophilic ligands. The modified particles were measured
using liquid scintillation counting (LSC) to determine the activity and ultimately, the total
number of 14C-oleic acid chains remaining after exchange. These techniques were used
to determine effects of head group chemistry with polymeric ligands and effects of head
group chemistry, number of binding groups, and ligand exchange reaction parameters
with small molecule ligands. Results revealed catechols displace the most oleic acid
during exchange. Furthermore, multidenticity, or multiple binding groups, increases the
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displacement of the oleic acid. Particle aging and oxidation was investigated using these
techniques. Unlabeled, oleic acid coated particles which were aged in solution for 2, 7,
and 30 days were mixed with 14C-oleic acid in exchange reactions. Results revealed that
aging of the particles at 30 days effected an increase in the amount of 14C-oleic acid
adsorbed on the particles after exchange. Kinetic analysis of these results indicated an
increase in the desorption rate constant and a decrease in the adsorption rate constant with
age but with no profound change in the overall reaction rates. A follow-up study with
oxidized particles suggested that this behavior may be due to oxidation during aging.
Overall, the results signify an increase in the number of available binding sites, possibly
due to formation of a defective oxide shell during aging and/or oxidation.
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CHAPTER 1: INTRODUCTION: SYNTHESIS, SURFACE
MODIFICATION, AND SURFACE CHARACTERIZATION OF IRON
OXIDE NANOPARTICLES
1.1

Introduction

Iron oxide nanoparticles have gained significant interest over the past few decades for use
in environmental and biomedical applications. The magnetic properties and
biocompatibility of these materials may be exploited for use in magnetic resonance
imaging (MRI) contrast agents,1, 2 magnetically modulated energy delivery (MagMED),3,
4

drug delivery,5, 6 and environmental remediation.7, 8 Manipulation of surface chemistry

of these nanoparticles is critical to achieve desirable properties for these applications.
There are various methods of synthesis and surface modification that allow for control
over size, shape, hydrophilicity or hydrophobicity, chemical functionality, and colloidal
stability of iron oxide nanoparticles.4, 9 One synthesis method of particular interest is
thermal decomposition of an iron precursor, which allows for optimal control over size
and size distribution.10-12 This method results in monodisperse particles with a
hydrophobic surface. The hydrophobic ligands are often replaced with hydrophilic
ligands through a process called ligand exchange to modify the nanoparticle surface.13, 14
There are multiple methods of nanoparticle surface modification. Some particle synthesis
techniques allow for in-situ control of surface chemistry, while others may require a postsynthesis technique like ligand exchange (Figure 1.1) or multi-step techniques using a
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grafting-to or grafting-from approach. Ligand exchange is a commonly used technique in
which an initial or sacrificial ligand is displaced by another ligand which competitively
binds to the surface of the particle.15, 16 This technique allows for change of the surface
chemistry without compromising the integrity of the core particle. Ligands used for these
reactions may be hydrophobic, hydrophilic, or ionic. The ligands may also bear multiple
functional groups which allow for reactive chemistries or for binding to biomolecules.
Furthermore, ligands may be used to control or manipulate particle size for certain
applications. Ligand chemistry is key to influencing particle stability and interactions
with the environment.

Figure 1.1. Illustration of general ligand exchange reaction on a nanoparticle.

Ligand exchange is dependent upon many factors. Ligand properties such as chain
length,17 head group chemistry,15 charge,18 and tail group chemistry19 can greatly affect
exchange and the rate of the reaction. Properties of the particle such as size, morphology,
surface defects, and oxidation state may also affect binding and exchange of the
ligands.20, 21 Several techniques exist which allow for analysis of ligand exchange and
the factors which influence it. These techniques include thermogravimetric analysis
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(TGA),22, 23 Fourier transform infrared spectroscopy (FTIR),22, 24 and x-ray photoelectron
spectroscopy (XPS).25, 26 However, some of these techniques are limited to qualitative or
semi-quantitative analysis only. Other techniques may have limited detection sensitivity.
Therefore, it is prudent to develop a technique which allows for quantitative analysis of
exchange with identifiable ligands at low detection limits. This dissertation focuses on
the use of radioanalytical methods for investigation and quantification of ligand exchange
of iron oxide nanoparticles and the factors that contribute to the reactions.
1.2

Synthetic Methods for Synthesis of Iron Oxide Nanoparticles

There are multiple approaches to synthesizing iron oxide nanoparticles. Some methods
are beneficial due to ease of synthesis and greater control of surface chemistry during the
reaction. Other methods allow for greater control of size and size distribution. However,
each of these methods have drawbacks which can affect the properties of the particles and
subsequent surface modifications. Coprecipitation is a common and easy route for
synthesizing iron oxide nanoparticles (Fe3O4 and -Fe2O3).27, 28 This technique involves
coprecipitation of ferrous and ferric salts in aqueous solutions at an adjusted pH.29
Magnetite (Fe3O4) particles can be made using a stoichiometric ratio of 2:1 (Fe3+/Fe2+) in
a pH range from 8 to 14.30 The first synthesis of superparamagnetic iron oxide
nanoparticles using co-precipitation was performed by Massart.31 Massart’s work
illustrated the importance of pH and the ratio of iron salts on size and size distribution of
the particles. Furthermore, his work and the work of others has demonstrated the ability
to synthesize coated particles with ligands such as dimercaptosuccinic acid (DMSA),32, 33
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citric acid,34, 35 and polymers like poly(ethylene glycol) (PEG)36 and PEG-b-poly(vinyl
phosphonic acid) (PVPA).37 Despite ease of synthesis and in-situ control of surface
chemistry, coprecipitation techniques do not typically yield particles with highly uniform
size, shape, and size distribution.38-40 Figure 1.2 demonstrates the relatively high the
polydispersity of co-precipitation particles.36 Control of these particle properties is key
for biomedical applications of iron oxides. High temperature methods like thermal
decomposition offer size and size dispersity control.

Figure 1.2. TEM image of iron oxide nanoparticles synthesized by a) coprecipitation36 and b)
thermal decomposition.

Thermal decomposition of an iron precursor is another common method which allows for
greater control and tuning of particle size and size dispersity (Figure 1.2). Hyeon and
coworkers synthesized monodisperse -Fe2O3 nanoparticles via subsequent oxidation of
iron nanoparticles.41 They heated iron pentacarbonyl and oleic acid in octyl ether at
100C for 1 hour, then oxidized the particles using trimethylamine oxide. This procedure
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yielded monodisperse, spherical particles which could be tuned to sizes between 4 and 16
nm. Sun et al. utilized thermal decomposition to synthesize magnetite (Fe3O4)
nanoparticles.42 Iron acetylacetonate was combined with oleic acid, oleylamine, and 1,2hexadecanediol in phenyl ether and heated to reflux under nitrogen. The reaction resulted
in particles which were 4 nm in diameter and were used in a seed-mediated growth
method to create larger particles. The nanoparticles were characterized via transmission
electron microscopy (TEM) and x-ray diffraction (XRD) and were shown to be highly
monodisperse.
Park et al. demonstrated a larger scale synthesis of iron oxide nanoparticles using a twostep approach.43 In their method, iron oleate was synthesized by mixing iron chloride
(FeCl3) and sodium oleate in ethanol, water, and hexane and heating the mixture to 70C.
The resulting precursor was purified, dried, and combined with oleic acid in octadecene.
The dissolved precursor was then thermally decomposed at 320C. This method was
used to generate monodisperse particles of varying sizes between 5 and 22 nm in
diameter. A group at Sandia National Laboratories has recently improved upon these
methods and developed a more highly controlled and reproducible synthesis of magnetite
nanoparticles.44 Vreeland et al. first synthesized an iron oleate precursor by heating iron
acetylacetonate and oleic acid in a molten metal bath to 320C. The resulting precursor
was adjusted to a concentration of 0.22 M using 1-octadecene. The precursor solution
was then injected at a constant rate into a flask containing oleic acid and docosane which
had been heated to 350C under a nitrogen atmosphere. The particle size was tuned by
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the duration of the reaction. The reproducible method allowed for synthesis of particles
up to 34.5 nm in diameter with low standards of deviation as determined by TEM image
analysis. Despite these remarkable advances in particle size tuning, thermal
decomposition results in particles which are hydrophobic. The high temperatures
necessitate the use of high-boiling, hydrocarbon solvents and ligands. Therefore, control
of surface chemistry is only achieved after synthesis of the nanoparticles.
Hydrothermal techniques require high temperatures for synthesis but allow for direct
formation of hydrophilic nanoparticles. Iron salts or hydroxides are heated to
temperatures which can exceed 200C and, therefore, are reacted at high pressures due to
the necessity of a closed reactor.29 Particle size and shape may be tuned by controlling
solvent conditions, temperature and time of reaction,45 and using additives like poly(vinyl
alcohol)46 or n-decylamine.47
Sol-gel is a wet-synthesis technique for synthesizing nanoparticles in a network or gel.
Typically, metal alkoxides are reacted with water to form metal hydroxides.29 Then the
metal hydroxides are condensed and polymerized with other metal hydroxides or
alkoxides to form a 3-dimensional network or gel. The gels are then dehydrated by heattreatment to obtain the nanoparticles.48 Manipulation of temperature, precursor
concentrations, and pH can result in formation of particles which are size-controlled and
fairly monodisperse.49
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1.3

Strategies for Surface Modification of Iron Oxide Nanoparticles

Control of surface chemistry is key to tailoring the properties of nanoparticles for various
applications. This can be achieved via several techniques including introduction of
ligands in-situ,32, 34, 36 click chemistry,50-52 layer-by-layer deposition,53, 54 ligand
exchange,11, 12 and grafting-from approaches like, atom transfer radical polymerization
(ATRP)55-58 and reversible addition-fragmentation chain-transfer polymerization
(RAFT).51, 59, 60 As previously mentioned, co-precipitation of iron oxide nanoparticles
allows for introduction of desired ligands in-situ. However, if greater control of particle
size and shape uniformity is critical to the application, then other particle synthesis
methods may be required necessitating the use of post-synthesis, surface modification
techniques.

Figure 1.3. Schematic of 1,3-dipolar cycloaddition of an alkyne and an azide resulting in the
formation of a triazole.

Click chemistry is a robust method which allows for fast and simple addition of
functional ligands onto nanoparticles. Shao et al. utilized azide-alkyne click chemistry to
modify polymer-coated iron oxide nanoparticles with carbohydrates.61 Dextran coated
nanoparticles were synthesized via coprecipitation and were subsequently modified via
perfluorophenylazide photochemically induced C-H insertion. Azide functional
carbohydrates were clicked on to the nanoparticles and they were investigated for their
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binding affinity to proteins and cells. Layer-by-layer (LbL) deposition is a slower, albeit
effective method which allows for modification of particles with multiple layers through
sequential adsorption of polymers with opposite charges (Figure 1.6).53, 62, 63 Choi and
coworkers modified amine-functional iron oxide nanoparticles using a centrifugation
layer-by-layer method for application as protein carriers.53 The particles were either
modified with poly(allylamine) hydrochloride and poly(acryclic acid), positive and
negatively charged graphene oxides, or poly-L-lysine and hyaluronic acid.
Characterization of the particles revealed successful depositions.

Figure 1.4. Representation of a general layer-by-layer deposition of polymers onto a
nanoparticle.

Grafting-from approaches offer precise control of structure and chain length of ligands on
the surface of nanoparticles. Polymers with specific architectures can be grown directly
from the surfaces of particles via highly controlled syntheses. For example,
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superparamagnetic iron oxide nanoparticles were modified by Eyiler et al. using surfaceinitiated ATRP.55 Briefly, amine functional nanoparticles were reacted with
bromopropionyl bromide. Itaconic acid and N-isopropylacrylamide were then
copolymerized from the bromine-initiated nanoparticles. Results revealed successful
modification of the particles with thermally and pH responsive copolymers.
Ligand exchange is a widely used and versatile technique for alteration of surface
chemistry without affecting the particle size or shape.64 Incidentally, this method is often
used in combination with the aforementioned techniques.57 Particles which were
synthesized with oleic acid may need to be modified via exchange with a ligand which
will serve as an initiator for polymerization or as a linker for other chemistries.57 Prai-in
and coworkers exchanged oleic acid with 3-aminopropyltriethoxysilane on the surface of
iron oxide nanoparticles which allowed for further conjugation of block co-polymers
containing azlactone rings which react with amines.60 Ligand exchange can be
performed in a variety of solvent systems and in the presence of catalysts or in high
temperature conditions to enhance the rate of the reaction.65-68 Furthermore, exchange is
heavily dependent upon the functionality of the ligands. The group which will bind to the
particle must have a higher affinity than that of the initial ligand.
1.3.1 Impact of Surface Chemistry on Applications of Nanoparticles
Manipulation of surface chemistry of nanomaterials is important, and in many cases,
required for generating materials which have all the necessary properties for desired
applications. Ligands may be used to confer solubility, colloidal stability, and
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functionality to the surfaces of nanoparticles (Figure 1.3). Ligands can be used to control
hydrophilicity or hydrophobicity, charge, functional groups for reactive chemistries or
adsorption, size, shape, and polydispersity. Control over the particle interface directly
impacts its behavior in any environment.

Figure 1.5. Illustration of ligands imparting a) colloidal stability and b) functionality to
nanoparticles.

Oleic acid-coated iron oxide nanoparticles cannot be dispersed in aqueous environments
for biomedical or environmental applications as synthesized. They must be modified
with natural or synthetic hydrophilic ligands. Synthetic ligands such as poly(ethylene
glycol) (PEG),69, 70 poly(vinyl alcohol) (PVA),71 poly(acrylic acid) (PAA),72
dimercaptosuccinic acid (DMSA),73, 74 and 3-aminopropyltriethoxysilane (APTES)75 are
commonly employed for biological applications and for environmental remediation.
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PEG is particularly useful for these applications because it’s biocompatible and helps to
increase circulation time of therapeutic materials.76, 77 Natural ligands like citric acid,13
alginates,78 natural organic matter (NOM),79 and chitosan80 have also been useful for
modification of nanoparticles for biomedical and environmental applications. Surface
ligands can also impart functionality and chemical reactivity to nanoparticles. As
mentioned in a previous section, iron oxide nanoparticles can be functionalized for
further polymerization from the surface. Polymers with functional tail groups like
carboxylic acids and amines can be used to conjugate biomolecules which can then be
used to target other moieties like cell receptor proteins.81 Nanoparticles may also contain
ligands which adsorb environmental contaminants.7 Whatever the application may be,
surface chemistry is critical to designing nanoparticles with the required properties.

Colloidal Stability
Surface ligands are not just important for solubility and functionality of nanoparticles;
they also provide colloidal stability. Aggregation of particles can be detrimental to their
purpose. Surface coatings can mediate this effect. The Derjaguin, Landau, Verway and
Overbeek (DLVO) theory is useful for modelling the interactions of particles in solution
(i.e. colloidal stability).82 Traditional theory states interparticle interactions are governed
by attractive forces or van der Waals forces (Va) and repulsive forces or electrostatic
forces (Ve). The interaction potential is determined by adding these forces together as
shown in Equation 1.1.
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Eq. 1.1) 𝑽𝒕𝒐𝒕𝒂𝒍 = 𝑽𝒂 + 𝑽𝒆
Particles with a surface charge attract counterions in the solution and layers of charges
form. This is referred to as the electrical double layer. According to DLVO theory,
stability can be achieved by balancing the double layer with attractive forces. However,
this theory has since been modified to include steric repulsive forces (Vs) and magnetic
interactions (Vm).83-86

Eq. 1.2) 𝑽𝒕𝒐𝒕𝒂𝒍 = 𝑽𝒂 + 𝑽𝒆 + 𝑽𝒔 + 𝑽𝒎
Ligands of sufficient size or length can provide enough steric hindrance to repel the
particles and overcome the attractive forces. Steric and electrostatic repulsion can be
achieved through surface modification (Figure. Ligands such as poly(acrylic acid), citric
acid, and zwitterionic dopamine sulfonate can provide both steric and electrostatic
stability. Polymers like PEG, which unless modified only provide steric stability, are
useful because the molecular weight of the chains can be tailored to optimize the stability
of particles of varying core sizes.

Figure 1.6. Illustration of colloidal stability through a) electrostatic forces and b) steric forces.
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1.3.2 Methods of Ligand Exchange
There is no single method of ligand exchange that is used amongst all researchers. The
ligand and the particle properties may even dictate the conditions of the ligand exchange.
However, there are some general methods that apply to most ligand exchange reactions.
Often, ligand exchange is performed in a homogeneous solution of either a single solvent
or two miscible liquids.87, 88 The coated particles and the incoming ligand are combined
in a medium which suits both. Ligand exchange reactions with oleic acid-coated particles
may be done in organic solvents like chloroform, toluene, or dimethylsulfoxide (DMSO)
depending on the solubility of the incoming ligand.15, 89, 90 The solutions of ligands and
particles are mixed through some mechanical action for a given period of time. The
particles may then be transferred to water after purification. These are common
conditions for many ligand exchange reactions.
In some cases, the new or incoming ligand may not be soluble in the same solvent or one
that is miscible with a solvent in which the particles are soluble. Therefore, a method
referred to as biphasic ligand exchange may be necessary as shown in Figure 1.7. This
method allows for a more direct transfer of the particles to the desired phase without the
use of harsh solvents for purification.91-93 Briefly, the particles are dispersed in either an
aqueous or organic phase depending on the initial surface chemistry. The incoming
ligand is dispersed in the opposite phase, and the two phases must be vigorously mixed
for the duration of the exchange reaction. The particles will slowly migrate to the desired
phase as they are coated with the new ligand. Phase transfer agents are sometimes used
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to achieve this exchange. Solvents like acetone may be added to decrease surface tension
at the interface of the phases.94, 95 Addition of acids or bases can alter the charge of the
ligands or nanoparticle surfaces and thus the solubility of the ligands and nanoparticles.94,
96, 97

However, extra steps may need to be taken in order to remove these agents from the

final particle solution.

Figure 1.7. Schematic of biphasic ligand exchange to modify nanoparticles.

1.3.3 Factors Which Affect Ligand Exchange
The ability to design and tune properties of ligands for optimal control of nanoparticle
surface chemistry is advantageous. Ligand properties greatly impact ligand exchange
reactions and their rates. Furthermore, solution conditions such as ionic strength and pH
may impact the behavior of the ligands and whether or not they bind to the particles.
Likewise, properties of the particle core can affect the nature of ligand binding. It is
imperative that all of these factors be considered when modifying nanoparticles through
ligand exchange (Figure 1.8).
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Figure 1.8. Illustration of factors which affect ligand exchange reactions of nanoparticles.

Head Group and Tail Group Chemistry
Selection of head group or binding group is key to controlling ligand exchange.
Functional groups such as carboxylic acids,98 phosphonic acids,99 catechols,100, 101
sulfonic acids,102 and silanes17 are widely investigated for their ability to bind to iron
oxides. The affinity of these anchoring groups for the surface of iron oxide particles is
critical to displacement of sacrificial ligands. Higher affinity anchoring groups will more
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readily anchor to the surface of the particle and drive the exchange reaction in a favorable
direction. Furthermore, these anchoring groups will not be as easily displaced by other
incoming ligands. Works by Amstad et al. have shown the high binding affinity of
catechol-derived anchoring groups for iron oxide surfaces versus other groups like
carboxlic acids.100 Furthermore, their work revealed that substitution of the catechols
affects binding with nitrocatechols having higher affinity than dopamine and mimosine
having such an affinity for iron oxide that it can cause dissolution of the particles.103
These investigations demonstrate the importance of choosing the appropriate binding
chemistry.

Figure 1.9. Illustration of common head groups for ligand exchange with iron oxides.

Although the impacts of end group chemistry on ligand exchange with iron oxides have
not been widely studied, effects on ligand exchange with gold particles have been
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investigated. End groups have been shown to impact rate of exchange depending on the
electronic nature of the substituents. Guo and coworkers used nuclear magnetic
resonance (NMR) spectroscopy to observe effects of NO2, CH3, and Br tail groups on
ligand exchange with phenylethanethiolates.19 Results revealed that ligand binding was
not affected by the tail group, but an activation barrier for initiation of exchange was
dependent on this chemistry with NO2-functionalized ligands exhibiting the highest rate
of exchange. These findings could suggest that there are impacts of tail groups on other
types of metal and metal oxide nanoparticles and should be further explored.

Multidentate Ligands, Chain Length, and Nanoparticle Environment
Not all ligands contain a single binding group. Some ligands have two or more head
groups which can bind to nanoparticle surfaces and are referred to as multidentate. These
types of ligands have been shown to bind more robustly than their monodentate
counterparts. In a study by Zhang and Han, FTIR and TGA were used to confirm
modification of iron oxide nanoparticles with two carboxyl-functional ligands. One of
the ligands had two groups and the other had only one functional group.104 Results
revealed greater surface coverage and the distinct presence of the multidentate ligand
compared to the monodentate version. A similar trend was seen by Miles et al. Their
work studied the effects of multidenticity on the modification of iron oxide nanoparticles
with PEO ligands which were anchored using a carboxylate group, an ammonium group,
a zwitterionic ammonium phosphonate group, and their trifunctional counterparts.18
Results showed greater stability of the multidentate-stabilized nanoparticles in DI water.
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Further studies in phosphate buffer saline (PBS) explored the nature of this enhanced
stability and the effects of nanoparticle environment on exchange. The particles which
were modified with the zwitterionic-anchored ligands showed the greatest stability in
PBS. This was due to the ability of the phosphonate anchoring groups to compete with
the phosphate salts in the medium for the surface of the particles. Furthermore,
desorption of the multi-anchored ligands due to this competition was much slower owing
to the increased number of binding groups per ligand. Introduction of sodium chloride
into the solutions of zwitterionic-anchored nanoparticles in DI water prevented
aggregation of the particles. This was attributed to a reduction in the “attractive
electrostatic interactions” of the zwitterionic groups on the negatively charged particle
surface. This work indicates not only the importance of multidenticity but also the
influence of environmental conditions on the surface exchange and stability of
nanoparticles.
The effect of chain length on ligand exchange of iron oxide nanoparticles can be largely
attributed to enhanced colloidal stability with increasing chain length. This was
evidenced by Barrera et al. in a study which looked at effects of increasing molecular
weight of PEG-silane ligands.17 Stability studies using dynamic light scattering (DLS)
showed aggregation of particles coated with 750 g/mol PEG versus those coated with
1000 g/mol, 2000 g/mol, and 5000 g/mol PEG ligands. They reasoned that the PEG 750
did contribute sufficient steric stabilization to overcome the attractive forces. Therefore,
since ligand exchange occurs in solution it should follow that insufficient steric
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stabilization could contribute to agglomeration of particles and thus, a less successful
ligand exchange reaction.

Nanoparticle Age and Oxidation State
Again, the effects of particle aging and oxidation of iron oxide nanoparticles on ligand
exchange are not widely understood. However, some studies of iron oxides and gold
nanoparticles could suggest the impacts of these processes. Chechik et al. observed a
decrease in ligand exchange reactivity of thiol-coated gold nanoparticles.105 Analysis via
TGA, UV-Vis, and electron paramagnetic resonance (EPR) confirmed that the thiols
were bound more strongly to the aged particles resulting in a stabilization of defect sites
where ligand exchange would normally occur. A study on aging of cobalt ferrite
nanoparticles resulted in changing the Fe/Co cation distribution and the formation of an
iron rich layer.106 This caused in an increase in crystallinity of the particles. A change in
metal ion distribution could result in an alteration of ligand binding due to selectivity of
metals for certain anchoring groups. Amstad et al. observed selectivity based on
oxidation state of iron.107 In their study, EPR measurements revealed a preferential
binding scheme of catechols to the Fe2+ oxidation state first then to the Fe3+ state. This
suggests that oxidation could increase or decrease ligand exchange reactivity depending
on the anchoring group.
1.4 Mechanisms of Ligand Exchange
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Currently, understanding and agreement of a single ligand exchange mechanism of
nanoparticles is debated amongst the scientific community. Some groups have reported
associative (SN2) mechanisms of exchange wherein an incoming ligand adsorbs or binds
to the surface of the particle while, at the same time, an outgoing ligand is desorbed and
leaves the surface (Figure 1.8a).108, 109 Others have reported dissociative (SN1)
mechanisms describing the desorption of the outgoing ligand before the adsorption of the
incoming ligand can occur (Figure 1.8b)110 Furthermore, truly mechanistic studies of
ligand exchange have been mostly limited to metal nanoparticles.64

Figure 1.10. Illustration of a) an associative ligand exchange mechanism and b) a dissociative
ligand exchange mechanism.

Despite a lack of research in mechanisms of ligand exchange of iron oxide nanoparticles,
some groups have sought to understand mechanisms of exchange on metal (hydr)oxides,
including hydrated iron complexes.111 In these studies, ligand exchange occurs in two
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steps. First, a weak and easily broken outer-sphere complex forms between the incoming
ligand and the metal (hydr)oxide. Second, displacement of a water molecule in an inner
coordination sphere allows for the incoming ligand to adsorb. In many cases this is
considered to be a dissociative mechanism whereby the second step is the ratedetermining step. Some researcher groups have shown that trivalent metal (hydr)oxides
like Fe(H2O)63+ exhibit selectivity towards certain incoming ligands resulting in an
associative mechanism of exchange.112, 113 Selective binding of certain functional groups
to iron and iron oxides has been well established and is a driving force of ligand
exchange. Likewise, the binding affinity of the outgoing ligand may also affect the rate
of exchange. For example, Tofan-Lazar and Al-Abadleh studied the effects of phosphate
adsorption of iron (oxyhydr)oxide films with arsenic already adsorbed to the surfaces.114
They used an attenuated total reflectance-Fourier transform infrared spectrometer (ATRFTIR) specially equipped with a flow through system to compare adsorption of
phosphates on oxide surfaces which were coated with arsenate and surfaces which were
coated with dimethylarsinic acid (DMA). A first-order, Langmuir adsorption kinetic
model was used to fit their data. Results showed concentration dependent, phosphate
adsorption rates on DMA coated films were up to 5 times higher than that of the arsenate
coated films. They attributed this to the structure of the arsenate molecules and the
ability for the ligands to leave. The methyl substitution of the DMA increased the
proportion of weakly bonded complexes in the outer-sphere.
1.5 Analytical Methods for Surface Characterization of Iron Oxide Nanoparticles
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Characterization of nanoparticle surface chemistry is important for confirmation of the
presence of surface bound ligands and for better understanding the processes used to
modify the particle surfaces. Analytical methods such as Fourier transform infrared
spectroscopy (FTIR), thermogravimetric analysis (TGA), X-ray photoelectron
spectroscopy (XPS), energy dispersive x-ray spectroscopy (EDX or EDS), ultravioletvisible spectroscopy (UV-Vis), and fluorescence spectroscopy may be used to
qualitatively or quantitatively characterize the surface of iron oxide nanoparticles. These
methods are used to confirm ligand exchange took place, confirm extent of ligand
exchange, determine kinetics of exchange, and observe binding of ligands. Each of these
methods offer advantages over others, but also maintain some limitations. Often, these
methods are used in combination to ensure a more complete analysis of the exchange.

FTIR
FTIR is a common method of characterizing surface modification of iron oxide
nanoparticles.115, 116 This technique is often used to qualitatively confirm ligand
exchange took place by identification of peaks due to key functional groups and
identification of peak shifts due to ligand binding.117, 118 This technique may be used to
monitor and quantify exchange reactions. As previously mentioned, Tofan-Lazar and AlAbadleh used ATR-FTIR to observe kinetics of exchange. Guenin et al. utilized FTIR to
determine surface coverage of a bisphosphonate ligand which was exchanged onto the
surface of iron oxide nanoparticles.119 They normalized their spectra to the iron oxide
vibration band at 500-600 cm-1 and utilized area measurements of the phosphonic
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function vibration bands to ascertain the bisphosphonate ratio per particle. The difficulty
with this method is that the iron oxide vibration band is not always easy to distinguish,
and this method cannot be used for accurate quantification of ligand exchange with
ligands of similar functionality due to peak overlap.

TGA
TGA is another common technique which is used to quantify modification of iron oxide
nanoparticles.120, 121 TGA is used to measure the total mass loss of the organic material
on the nanoparticles as the sample is heated. The mass loss can be used to further
determine average surface coverage of the ligands on the nanoparticles. In one study,
Durdureanu-Angheluta and coworkers utilized TGA to characterize organic mass loss on
oleic acid-coated iron oxide nanoparticles which were modified in an exchange process
with 3-aminopropyltriethoxysilane (APTES).122 They further characterized the particles
using FTIR and XPS to identify the presence of the ligands on the particles. Combining
characterization methods for analysis is common practice and often necessary due to a
disadvantage of TGA. TGA is not a qualitative technique. This method does not allow
for accurate distinction between different types of organic ligands present on the
particles.

UV-Vis and Fluorescence Spectroscopy
UV-Vis is a less typical method of ligand exchange characterization. Iron oxide
nanoparticles absorb in the UV-visible range making this method difficult for
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characterization of ligands bound to the particles. However, this method can be used in
cases where the ligands have been removed from the surface of the particles. For
example, oleic acid-coated iron oxide nanoparticles were modified with tetraethylene
glycol-based phosphonate ligands which were previously synthesized using click
chemistry.123 The ligand exchange was monitored using UV-Vis. The supernatant
solutions generated from purification of the modified particles were analyzed to
determine the quantity of the hydrophilic ligands which remained and were not
exchanged onto the particles. The issue with this method is that it relies on ligands which
exhibit signatures in the UV-Vis spectral range. The ligands in this study were
synthesized using click chemistry which incorporated benzyl and triazole rings into the
ligands.
Fluorescence spectroscopy is yet another technique which can only be used with ligands
which exhibit unique spectral properties. This technique is used to monitor surface
modification and ensure binding of ligands to the particles. Qu et al. utilized
fluorescence spectroscopy to confirm modification with amine and carboxylic acidcapped iron oxide nanoparticles.124 They conjugated fluorescein or rhodamine B to the
functional ligands. Observed decreases in the quantum efficiency and lifetime of
fluorescein after conjugation to citric acid-capped particles confirmed successful
modification due to quenching from the covalent attachment of the fluorescein molecules.
However, in order to determine the absorbance of the fluorescent molecule-conjugated
nanoparticles, the particles had to be dissolved in hydrochloric acid. The poor optical
properties of iron oxide nanoparticles make this technique more difficult for analysis of
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ligand exchange. Another drawback of this method is the requirement of fluorescent
molecules which may limit the available surface chemistries.

XPS and EDX
XPS and EDX are techniques which can be used to obtain elemental composition on the
surface of iron oxide nanoparticles.125, 126 XPS measures kinetic energy and the number
of electrons which are emitted after irradiation of the particle surface with an x-ray
beam.127 EDX or EDS measures x-rays emitted due to excitation of inner shell
electrons.128 De Palma and coworkers used XPS to characterize amino, carboxylic acid,
and PEG-terminate silanes.116 They were able to determine elemental composition on the
surface, thicknesses of the silane layers, and measure the binding energies of the ligands.
The binding energies revealed the binding mechanisms or schemes of the functional
groups to the iron oxide surfaces. These techniques can be combined with the other
previously discussed methods to develop a more complete quantitative analysis of the
particle surface. In one study EDS and TGA were used in combination to determine
surface coverage of APTES-coated magnetite nanoparticles for further modification with
polyamidoamine dendrimers.129 Elemental analysis and mass loss from TGA
measurements allowed for calculation of approximately 610 APTES ligands per
nanoparticle. Despite the quantitative advantage of these techniques, they maintain some
disadvantages. Techniques which rely on elemental analysis to identify surface ligands
are highly sensitive to contaminants. EDX is limited due to spectral overlap of different
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elements. Furthermore, elemental analysis alone may not be sufficient if multiple types
of ligands are present on the surface.
1.6 Conclusions and Future Outlook
Ligand exchange is a widely applicable method of surface modification with iron oxide
nanoparticles. This technique is critical for transforming hydrophobic particles to welldesigned, hydrophilic particles for a variety of applications. Furthermore,
characterization of the nanoparticles is imperative to qualitatively and quantitatively
confirm the ligand exchange reaction occurred and to what extent. However, current
characterization techniques are limited by detection sensitivity, limited to being only
qualitative or quantitative, or limited by the available chemistries. Herein, radioanalytical
methods for quantitative analysis of ligand exchange on iron oxide nanoparticles are
described. The following chapters discuss the use of a radiotracer (14C) to label
nanoparticle ligands and radiometric detection of those ligands via liquid scintillation
counting. Various factors which affect ligand exchange were investigated using these
techniques. Chapter 2 includes studies of ligand exchange of radiolabeled, iron oxide
nanoparticles with PEG ligands containing different head groups. Chapter 3 expands
these techniques to investigations of ligand exchange with various small molecule
ligands. Techniques commonly used with these ligands are compared to a standardized
ligand exchange technique to isolate the contribution of head group chemistry on
exchange. Chapter 4 contains a kinetic study of ligand exchange and discusses the
effects of particle aging and oxidation on the exchange of oleic acid. Chapter 5 extends
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the application of these radioanalytical techniques to the modification of drugs with
radiolabeled polymers. LSC is a highly sensitive technique which can be used to detect
even low levels of polymer-drug conjugate in a biodistribution study. Finally, this
document will conclude with a discussion of future directions of this research.
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CHAPTER 2: DIRECT MEASUREMENT OF LIGAND EXCHANGE ON
IRON OXIDES WITH POLYMERIC LIGANDS VIA
RADIOANALYTICAL TECHNIQUES
Reproduced with permission from [Davis, K.; Witmer, M.; Qi, B.; Powell, B. A.;
Kitchens, C. L.; Mefford, O. T., Quantitative measurement of ligand exchange on iron
oxides via radiolabeled oleic acid. Langmuir 2014, 30, 10918-10925.] Copyright [2014]
American Chemical Society
2.1 Introduction
Control of surface chemistry and colloidal properties is critical for applications of iron
oxide nanoparticles. Ligand exchange is a particularly useful tool for surface
modification of these materials. Hydrophobic, iron oxide nanoparticles synthesized via
thermal decomposition are not suitable for direct application in aqueous or biological
media. The particles must be modified for transfer to water, and this is often done
through ligand exchange with hydrophilic polymers. PEG is a commonly used ligand for
coating iron oxide nanoparticles, especially for biomedical applications.17, 69, 130, 131 PEG
has relatively high stability, water solubility, and low immunogenicity.76, 132, 133
Furthermore, it has been shown to enhance circulation time of biomolecules.77, 134, 135
Despite these advantages of PEG, if a full ligand exchange does not occur, the result is a
heterogeneous mix of hydrophilic and hydrophobic patches on the surface of the
nanoparticle, which can affect the colloidal stability of the particles in solution.
Relatively little research has been done to quantify the amount of hydrophobic ligand that
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is exchanged and determine the binding hierarchy of different ligands. Furthermore,
typical methods for measuring ligand exchange such as FTIR, EDS, and TGA may not be
sufficient for accurate quantification of exchange due to detection or sensitivity limits or
inherent assumptions of complete exchange.
This chapter introduces radioanalytical methods, which we have previously published, to
synthesize iron oxide nanoparticles with radiolabeled capping ligands and use liquid
scintillation counting (LSC) to measure how much radiolabeled oleic acid has been
displaced on the surface of the nanoparticles through exchange with a hydrophilic PEG
ligand.15 Radiolabeled and unlabeled magnetite iron oxide core nanoparticles (Fe3O4)
were synthesized with oleic acid as the capping ligand. During the synthesis of the
radiolabeled nanoparticles unlabeled oleic acid and oleic acid [1-14C] were added as to
the reaction mixture. As illustrated in Figure 1, the labeled and unlabeled particles were
then modified in chloroform with PEG ligands terminated with either a carboxylic acid
group (-COOH), a nitroDOPA group, a DOPA group, a phosphonate group (-PO(OH)2),
or an amine group (-NH2) as the group that binds to the surface of the nanoparticle. The
particles were purified to remove excess unbound ligands. The amounts of radioactive
oleic acid in samples of each particle solution before and after ligand exchange were
determined using LSC. The radiolabeled particles were further characterized by dynamic
light scattering (DLS) and transmission electron microscopy (TEM). The unlabeled
particles were synthesized and modified to compare LSC to other methods commonly
used to characterize modified particles. The unlabeled particles were characterized by
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dynamic light scattering (DLS), transmission electron microscopy (TEM), vibrating
sample magnetometry (VSM), and thermogravimetric analysis (TGA).

Figure 2.1. Illustration of radioanalytical techniques to quantify ligand exchange.

2.1.1 LSC Theory
LSC is a technique used to detect the presence of emitted low and high energetic beta
particles and some alpha and gamma-ray emitters. This technique is used to determine
activity of a radioactive sample and in some cases, can be used to identify an unknown
radionuclide.136 LSC works based on detection of photons generated from interactions of
emitted particles with the surrounding liquid scintillation cocktail. Beta or alpha beta
particles resulting from decay produce excited molecules in solution. The excited
molecules either produce photons or transfer energy to an acceptor which will then emit
photons.137 The number of photons generated is dependent upon the number of excited
molecules produced by the alpha or beta particles. The photons are detected by
photomultiplier tubes which convert them to an electrical signal. Liquid scintillation
counters can determine the number of photons generated over a specific amount of time
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or counts per minute (cpm). These counts per minute can be converted to decays per
minute (dpm) using a determined counting efficiency of the observed radionuclide.
Decays per minute can be directly related to activity.
Liquid scintillation cocktails are typically composed of aromatic organic solvents,
surfactants or emulsifying agents, and fluorescent molecules or scintillators. While
aromatic solvents may aid in the transfer of energy, fluorescent molecules such as 2-(4tert-Butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole (butyl-PBD) or p-terphenyl, act
as efficient scintillators or acceptors in the solution.137 Interaction of beta of alpha
particles with the  cloud of an aromatic ring results in capture of the energy which can
then be transferred to another solvent molecule or to a fluorescent molecule. This results
in excitation of electron levels in the fluorescent. Photon emission from the scintillator
molecule results from decay from the excited singlet state to the ground state.137 This
technique allows for sensitive detection of ionized particles due to the proximity and
close interactions of the particles, solvents, and fluorescent molecules.

2.2 Experimental
2.2.1 Materials
Iron (III) chloride hexahydrate (ACS, 97, 0-102.0%), 3,4-dihydroxy-DL-phenylalanine
(DL-DOPA; crystalline, 98%), and sodium nitrite (≥97%) were purchased from Alfa
Aesar. Poly(ethylene glycol) methyl ether (avg. Mn 5000), ethylene oxide monomer
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(≥99.5%), 4-(dimethyl amino) pyridine (≥99%), N-hydroxysuccinimide (98%), N,N’dicyclohexyl carbodiimide (99%), potassium bis(trimethylsilyl)amide (95%; 1 M in
THF), and succinic anhydride (≥99% (GC)) were purchased from Aldrich. (2aminoethyl) phosphonic acid (99%), dimethylformamide (99.8%, extra dry over
molecular sieves, AcroSeal®), and 1-octadecene (90%, technical grade) were purchased
from Acros Organics. Ethyl ether (>95%) and chloroform (CHCl3, 99.8%) were
purchased from AvantorTM Performance Chemicals. Ethanol (anhydrous, histological
grade) and hexanes (99.3%) were purchased from Fisher Chemical. Oleic acid was
purchased from EMD. Tetrahydrofuran (99%) was purchased from BDH chemicals.
Sodium oleate (≥97%) was purchased from TCI America. Optiphase ‘HISAFE’ 3 liquid
scintillation cocktail and oleic acid [1-14C] (>97%) were purchased from PerkinElmer.
Bio-Beads SX-1 support (styrene-divinylbenzene copolymer beads) were purchased
from Bio-Rad Laboratories, Inc.
2.2.2 Nanoparticle Synthesis
In order to synthesize oleic acid coated Fe3O4 nanoparticles for ligand exchange that were
approximately 10 nm in diameter, we modified a procedure reported by Park et al.43 The
procedure was performed twice in order to synthesize radiolabeled and unlabeled
particles separately. To synthesize the iron oleate precursor 0.811 g (5 mmol) of FeCl3,
4.56 g (15 mmol) of sodium oleate, 10 mL of ethanol, 7.5 mL of DI water, and 17.5 mL
of hexane were added into a three-neck, round bottom flask. The reaction mixture was
stirred via a magnetic stir bar as the solution was heated to 60 °C at 5 °C/min and
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refluxed for four hours. The top, organic layer containing the iron oleate was washed with
DI water.
To synthesize the Fe3O4 nanoparticles the iron oleate precursor (5 mmol, assuming 100%
conversion), 2.5 mL of oleic acid, and 50 mL of octadecene were added to a three-neck,
round bottom flask. To synthesize the 14C-oleic acid coated Fe3O4 nanoparticles, 50 μCi
of 14C-Oleic acid was added during this step. Given the high concentration of stable oleic
acid, the 14C-oleic acid serves as a tracer and does not significantly add to the total mass
of oleic acid in the system. The reaction mixture was stirred via a magnetic stir bar and
heated to 110°C at 5 °C/min and held at that temperature for one hour. The reaction was
then heated at 3 °C/min to 320 °C and held to reflux for two hours. The resulting
nanoparticles were washed 5 times with ethanol and hexane then dispersed in chloroform.
Some of these nanoparticles were injected into 12,000-14,000 MWCO Spectra/Por®
dialysis tubing, placed in chloroform, and put on a shake plate to stir for 72 hours. The
amount of 14C-oleic acid was monitored in each purification step using LSC.
2.2.3 Polymer Synthesis
In this study a series of five, modified poly(ethylene glycol) (PEG) polymers were
synthesized for use in the ligand exchange with oleic acid on the surface of the
nanoparticles. The structures of these polymers are shown in Figures 2.2, 2.3, 2.5, 2.6,
and 2.8. Two catechol-derived anchor groups, DOPA and nitroDOPA, were of particular
interest to this study as they have been shown by Amstad et. al. to bind with great affinity
to iron oxide nanoparticles.100, 107 Results from these studies on various catechol groups
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indicated strong, irreversible binding of nitroDOPA to iron oxide thus providing good
colloidal stability of the nanoparticles. The nitroDOPA was bound strongly to the surface
but not with an affinity so high to cause dissolution of the nanoparticles as with the
mimosine. These polymers and a carboxylic acid terminated PEG polymer were
synthesized according to previously published procedures.101 A phosphonate terminated
PEG was synthesized by a modified version of those published procedures. An amine
terminated PEG was synthesized according to a procedure reported by Stone et al.138
Following synthesis each polymer was purified by vacuum filtration. The polymers were
further purified 3 times each by precipitation in ethyl ether, re-dispersion in chloroform,
and isolation by centrifugation at 10,000 rpm. The polymers were dried at room
temperature in a vacuum oven at 30 in.Hg (14.7 psi) overnight to remove solvent.
A carboxylic acid (-COOH) terminated PEG polymer was synthesized by first drying 5 g
of poly(ethylene glycol) methyl ether (avg. Mn 5000) in an Erlenmeyer flask in a vacuum
oven at 80°C overnight. The polymer was then dissolved in 20 mL of tetrahydrofuran
(THF) and reacted with succinic anhydride in a 1:1.5 molar ratio of PEG to succinic
anhydride (Figure 2.2). 4-(dimethyl amino) pyridine was used as a catalyst in a 1:0.01
molar ratio of PEG to 4-(dimethyl amino) pyridine. The solution was stirred via a
magnetic stir bar for eight hours and was purified by the aforementioned procedure.
Polymer modification was verified by nuclear magnetic resonance (NMR) spectroscopy
by peaks at 2.65 ppm (O=C=CH2-CH2=C=O, addition of succinic anhydride), 3.4 ppm
(O-CH3, methoxy end group), 3.67 ppm (O-CH2-CH2-O, PEG).
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Figure 2.2. Modification of PEG with succinic anhydride.

A nitroDOPA terminated PEG polymer (5000 MW) was synthesized from the previously
synthesized PEG-COOH (Figure 2.3). The dried PEG-COOH polymer was dissolved in
20 mL of anhydrous THF and reacted with N-hydroxysuccinimide (NHS) in a 1:1molar
ratio. N,N’-dicyclohexyl carbodiimide (DCC) was used as a catalyst in a 1:1.25 molar
ratio of PEG-COOH to DCC. The solution was stirred via a magnetic stir bar for four
hours. The resulting PEG-NHS product was filtered by vacuum filtration. The collected
filtrate was rotary evaporated, precipitated with ethyl ether, centrifuged, and left to dry in
a vacuum oven overnight. The dried polymer was dissolved in 20 mL of dry
dimethylformamide (DMF). The DMF was dried over molecular sieves prior to
dissolving the polymer. NitroDOPA was added to the polymer solution in a 1:1.5 molar
ratio of PEG-NHS to nitroDOPA. The solution was stirred via a magnetic stir bar
overnight and purged with nitrogen for the first ten minutes of the reaction. The final
product was purified before use. NMR was used to verify the polymer modification by
peaks at 2.65 ppm (O=C-CH2-CH2-C=O, addition of succinic anhydride), 2.88 and 2.95
ppm (CH2-CH2, DOPA), 3.4 ppm (O-CH3, methoxy end group), 3.7 ppm (O-CH2-CH2-O,
PEG), 8.0 ppm (CH, ring, DOPA).
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Figure 2.3. Modification of PEG with NHS and nitroDOPA.
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Figure 2.4. NMR spectra of a) PEG-COOH and b) PEG-nitroDOPA.

The nitroDOPA utilized in the PEG-nitroDOPA synthesis was synthesized prior to
polymer synthesis. First, a 250 mL round bottom flask containing 100 mL of DI water
and a magnetic stir bar was placed in an ice bath at 0 °C. 1.97 g (9.99 mmol) of DLDOPA was added to the flask as the solution stirred. Following that, 1.52 g (17.88
mmol) of sodium nitrite was added to the flask while stirring. 0.92 mL of sulfuric acid
(96 wt%) in 10 mL of DI water was added dropwise to the mixture via an additional
funnel until it became a yellow, golden color. The resulting product was vacuum filtered
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and washed with water and methanol to remove impurities. The product was dried in a
vacuum oven.
The first two steps of the synthesis of a phosphonate terminated PEG were the same as
those for the synthesis of the nitroDOPA terminated PEG. The previously synthesized
PEG-NHS polymer was reacted with (2-aminoethyl) phosphonic acid in a 1:1 molar ratio
of PEG-NHS to acid (Figure 2.5). The reaction occurred in DI water with a pH adjusted
to seven by addition of NaOH. The solution was stirred via a magnetic stir bar for four
hours. The resulting solution was poured into a separatory funnel. DI water was added
to the separatory funnel in a 1:1 volume ratio of polymer solution to water. The mixture
was allowed to sit overnight and the bottom layer containing the polymer was collected,
precipitated with ethyl ether, centrifuged, and dried in a vacuum oven overnight. The
polymer modification was verified with NMR by peaks at 1.9 ppm (CH2-P(=O)(OH)2),
2.7 ppm (O=C=CH2-CH2=C=O, addition of succinic anhydride), 4.15 ppm (HO-), 3.4
ppm (O-CH3, methoxy end group), 3.7 ppm (O-CH2-CH2-O, PEG).

Figure 2.5. Modification of PEG-NHS with phosphonic acid.
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Again, the first two steps of the synthesis of a L-DOPA modified PEG were the same as
those for the synthesis of PEG-nitroDOPA and PEG-phosphonate. The previously
synthesized PEG-NHS polymer was reacted with 3,4-dihydroxy-phenylalanine in a 1:1
molar ratio of PEG-NHS to L-DOPA (Figure 2.6). The reaction was performed in 20 mL
of dry DMF which was purged with nitrogen for the first ten minutes of the reaction. The
solution was stirred via a magnetic stir bar for 8 hours and purified after reaction. The
polymer modification was verified using NMR by peaks at 2.65 ppm (O=C=CH2CH2=C=O, addition of succinic anhydride), 2.9 and 2.95 ppm (CH2-CH2, DOPA), 3.4
ppm (O-CH3, methoxy end group), 3.65 ppm (O-CH2-CH2-O, PEG), 8.0 ppm(CH, ring,
DOPA).

Figure 2.6. Modification of PEG-NHS with L-DOPA.
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Figure 2.7. NMR spectra of a) PEG-phosphonate and b) PEG-DOPA.

A protected, NH2 terminated poly(ethylene oxide) (PEO) polymer with a molecular
weight of 5,000 g/mol was synthesized via anionic polymerization using a high pressure,
stirred, model 4566 mini bench top Parr reactor to create a closed, oxygen and water free
environment (Figure 2.8). First, the reactor was purged and vacuum was pulled three
times. The temperature of the reactor was lowered to -35°C using acetone and liquid
nitrogen. At this low temperature 8.61 g (195.46 mmol) ethylene oxide (EO) was
distilled into the reactor. Tetrahydrofuran (THF, 110 mL) was added via syringes to the
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reactor and the solution began stirring. At approximately 40 °C 0.31 g (1.55 mmol) of
potassium bis(trimethyl silyl amide) NH2 was added via a syringe followed by 10 mL of
THF. The reactor was then brought to room temperature and stirred for 72 hours. The
resulting product was purified, dried, and deprotected with HCl. To deprotect the
polymer 1 g of polymer was added to an Erlenmeyer flask and dissolved in 10 mL of
THF. As the solution stirred via a magnetic stirrer approximately 10 to 20 drops of HCl
was added and the reaction mixture was stirred overnight and purified after reaction. The
modification of the polymer was confirmed by NMR with peaks at 2.4 ppm (CH2-NH2,
protons next to amine end group), 3.3 ppm (CH2-OH, protons next to hydroxyl end
group), and 3.7 ppm (O-CH2-CH2-O, PEG).

Figure 2.8. Synthesis and deprotection of PEG-amine.
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Figure 2.9. NMR spectra of PEG-amine.

2.2.4 Ligand Exchange
Equal amounts of the synthesized particles were modified with either PEG-COOH, PEGnitroDOPA, PEG-phosphonate or PEG-NH2 to monitor the displacement of 14C-oleic
acid via ligand exchange (Figure 2.10). To modify the particles, 0.02 mmol of each
modified PEG polymer was dissolved in chloroform in a 20 mL scintillation vial. The
vial was capped with a rubber septum and sonicated while 10 mg of nanoparticles in
chloroform was added dropwise to the polymer solution. After addition of the particles,
the polymer-particle solution was put on a shake plate to mix overnight. The resulting
particles were precipitated using ethyl ether, centrifuged, and re-dispersed into water.
The polymer-particle solutions were further purified using dialysis to remove excess
ligand. The solutions were injected into 12,000-14,000 MWCO Spectra/Por® dialysis
tubing, placed in water, and put on a shake plate to stir for 72 hours. The waste from
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purification was monitored using LSC. The ligand exchange procedures using each of
the five different ligands were performed simultaneously.

Figure 2.10. Illustration of a ligand exchange reaction. 14C-oleic acid coated nanoparticles
undergo a ligand exchange reaction with one of the five monofunctional PEG ligands resulting in
hydrophilic particles.

2.2.5 Gel Permeation Chromatography (GPC) Column
LSC and TGA of the purified and dialyzed oleic acid coated particles indicated a large
amount of oleic acid remained on the surfaces despite efforts to remove much of it.
Although these dialyzed particles containing excess oleic acid were used in the ligand
exchange reactions, the need for a better method of removal in future studies remains. In
order to remove the excess oleic acid, the radiolabeled and unlabeled as synthesized,
oleic acid coated particles were each passed through burettes containing styrenedivinylbenzene copolymer beads swollen in toluene (Figure 2.11).139 The beads were
swollen in toluene overnight and poured into the burette in order to pack the column with
the gel. The burette or column through which the unlabeled particles were passed was
larger and contained more beads than the column that the radiolabeled particles were
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passed through. A concentrated sample of nanoparticles in toluene was added to the top
of the column, allowed to pass completely through the column as a dark band, and
collected at the bottom for further analysis. The radiolabeled particles were characterized
by liquid scintillation counting and the unlabeled particles were characterized by
thermogravimetric analysis.

Figur e 2.11. Nanoparticles passing through a GPC column.
2.2.6 Characterization
Transmission electron microscopy (TEM) was used to determine the core size of the
labeled and unlabeled nanoparticles. The samples were prepared by dilution of the
nanoparticle solution and application to a copper grid with carbon mesh. TEM images
were obtained on a Hitachi H7600 with an accelerating voltage of 120 kV. Image
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analysis to determine particle size and distribution was performed using Adobe
Photoshop® and Kaleidograph®. Lognormal fits of the particle distributions were
performed using MATLAB to determine average particle surface area and average core
diameter.
Dynamic light scattering (DLS) was used to determine the hydrodynamic diameter of the
modified and unmodified particles. The nanoparticle solutions were diluted with water or
hexane and put into a cuvette. Each unlabeled sample was measured three times at 25 °C
using a Malvern Zetasizer Nano ZS to determine the intensity average size distribution
and z-average diameter. Each radiolabeled sample was measured three times at 25 °C
using a Brookhaven 90Plus with ZetaPALS to determine the size distribution and
effective diameter. Although the Malvern instrument reports a z-average diameter and
the Brookhaven reports an effective diameter, studies by Jaeger et. al. show that both
instruments report the same average diameter of the particles.140
The surface potential of the nanoparticles was determined using zeta potential
measurements. The modified and unmodified particles were measured before and after
dialysis. The nanoparticle solutions were diluted with water or hexane and put into a zeta
cell or a cuvette with a dip cell. Each sample was measured three times at 25 °C. Again,
the particles without radiolabeled ligands were measured using a Malvern Zetasizer Nano
ZS and the radiolabeled particles were measured using a Brookhaven 90Plus with
ZetaPALS.
Thermogravimetric analysis (TGA) was used to determine surface coverage of the
ligands on the surface of the nanoparticles before and after modification. Approximately
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5 to 10 mg of sample was placed in a TGA pan, which was analyzed using a TA
Instruments Hi-Res 2950 Thermal Gravimetric Analyzer. The samples were heated to
110 °C at 20 °C/minute, held at that temperature for 30 minutes, then heated to 800 °C at
15 °C/minute. The surface coverage of the ligands on the nanoparticles in chains/nm2
was determined by a series of calculations. First, the total surface area of the
nanoparticles in 1 gram of nanoparticle/polymer complex was determined using the
average particle diameter and average surface area yielded by TEM image analysis. The
TGA percent weight loss value and the density of magnetite were used to determine the
total volume of nanoparticles in 1 gram of complex. This value divided by the volume of
one nanoparticle multiplied by the surface area of one nanoparticle yielded the total
surface area. Second, the number of chains in 1 gram of complex was determined using
the molecular weight of the polymer and Avogadro’s number. Finally, the number of
chains was divided by the total surface area to yield the total surface coverage in
chains/nm2.
Vibrating sample magnetometry was used to verify the magnetic properties of the
particles. The VSM sample was prepared by adding a few drops of the unlabeled, oleic
acid coated nanoparticles onto a piece of scotch tape and drying it overnight. The sample
was analyzed at 300K in a 3T field with a Quantum Design VSM which runs on the
physical property measurement system 6000 (PPMS 6000).
Inductively coupled plasma-mass spectroscopy (ICP-MS, ThermoScientific MS XSeries
2) was used to determine the concentration of the nanoparticles in solution. Aliquots of
the samples were digested with a 2% nitric acid solution in a 15 mL centrifuge tube.
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Liquid scintillation counting (LSC) was employed as the method of tracking the
exchange of the radiolabeled ligand with the unlabeled, hydrophilic ligands. Samples of
the nanoparticle particle solutions were digested with concentrated nitric acid (HNO3) to
minimize color quenching and added to a 20 mL vial. Samples of the waste solutions
from purification were not digested due to their minimal color quenching. These aliquots
from the waste solutions were also added to 20 mL vials. A scintillation cocktail was
then added to the vials and mixed with the sample. The samples were analyzed using a
Hidex 300 SL automatic liquid scintillation counter. MikroWin Hidex 2000 v.4.43
software was used to view and analyze the sample data. Furthermore, the amount of
color quenching in each sample was determined using a Perkin Elmer TriCarb 2910 TR
LSC instrument. The quench data was used to verify or correct the counting efficiency
determined using triple-to-double coincidence counting measured in situ on the Hidex.
2.2.7 Calculation of Oleic Acid Surface Coverage on Nanoparticles
The LSC data and ICP-MS data were used to calculate the amount of oleic acid present
on the surface of the nanoparticles before and after ligand exchange. The calculated
amounts were compared to determine a hierarchy of binding of the different hydrophilic
ligands utilized in the procedures. The LSC results are initially reported in counts per
minute. This data can be converted to decays per minute (dpm) and used to determine
the moles of 14C-oleic acid per milliliter of solution using the equation below:
Eq. 2.1)

𝒎𝒐𝒍𝒆𝒔 𝟏𝟒𝐂
𝒎𝒍

=

(𝒔𝒂𝒎𝒑𝒍𝒆 𝒄𝒑𝒎−𝒃𝒂𝒄𝒌𝒈𝒓𝒐𝒖𝒏𝒅 𝒄𝒑𝒎)⁄𝑻𝑫𝑪𝑹/𝒎𝒍
𝐥𝐧(𝟐)
×(𝟔.𝟎𝟐𝟐×𝟏𝟎𝟐𝟑 )
𝒕𝟏/𝟐
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where the numerator represents dpm, TDCR is the triple-to-double coincidence ratio used
to account for detection efficiency, cpm is counts per minute, the denominator is the
decay constant ((λ) is 2.3*10-10 min.-1 for 14C) multiplied by Avogadro’s number, and the
half-life (t1/2) is 5,730 years for 14C. This value was used to determine the total amount of
oleic acid per milliliter of sample, assuming a constant ratio of radiolabeled to unlabeled
oleic acid and accounting for oleate ligands from the precursor. The ICP-MS data was
used to determine the concentration of particles in solution. Knowing the average surface
area of the particles determined from the lognormal fit of the size distribution, a
normalized surface area per unit volume of sample was calculated. Finally, using the
oleic acid concentration and the surface area concentration, the total amount of oleic acid
per nm2 of Fe was calculated.
2.3 Results and Discussion
Nanoparticles were synthesized via thermal decomposition and modified via ligand
exchange. The particles were characterized to determine size, hydrodynamic diameter,
surface potential, magnetic properties, and surface coverage of the ligands. The particles
were also analyzed by LSC to quantify the amount of radioactive oleic acid present on
the surface of the particles before and after ligand exchange.
2.3.1 TEM
Analysis of the TEM images yielded size distributions (Figure 2.6) for the unlabeled and
labeled particles. Lognormal fits of the distributions produced the average surface area
from which the average diameters of the particles could be determined. The average core
diameter of the unlabeled particles was 10.6 nm with a standard deviation of 2.24 nm and
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10.0 nm with a standard deviation of 2.26 nm for the labeled particles. (Figure 2.12) The
wide size distributions of the particles can be explained by the inability to perform
syntheses of these particles under nitrogen while purging which would have allowed for
greater control of size and size distribution. Purging the radiolabeled reaction might have
released radionuclides into the atmosphere. Furthermore, the synthesis of the unlabeled
particles was performed the same for procedural consistency. The size distributions
were accounted for in the average surface area calculations by the lognormal fits of the
histograms. The sizes, determined from the average surface areas, were used in the
calculations to determine the amount of ligand present on the surface of the nanoparticles.
These calculations for surface coverage by TGA are discussed in an earlier section and
calculations for surface coverage by LSC are discussed in a later section.
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Figure 2.12. TEM image (left) and size analysis (right) of the unlabeled nanoparticles (top) and
the radiolabeled nanoparticles (bottom). The histogram shows the size distribution of the
nanoparticles.

2.3.2 DLS
The hydrodynamic diameters of the particles were determined using DLS. This yielded
information about the size of the particles with oleic acid on the surface and with the new
hydrophilic ligands on the surface. The data in Table 2.1 summarizes the results for the
particles and shows good agreement in trends and values between the labeled and
unlabeled particles. The addition of the PEG brushes yields an increased hydrodynamic
diameter between 80 nm and 100 nm for the PEG-DOPA and PEG-nitroDOPA particles,
which agrees with previous studies by our group.101, 141 The zeta potentials of the PEG-
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DOPA and PEG-nitroDOPA particles are not very negative and are relatively close to
zero indicating that electrostatic repulsion does not play a large role in particle
stabilization. This is expected for particles coated in PEG as the methoxy end groups
exposed to the water do not carry a charge. However, the more negative zeta potentials
of the PEG-Phosphonate, PEG-COOH, and PEG-NH2 particles may indicate the presence
of excess ligands in solution or at the surface of the particles yielding a surface charge.
The increased hydrodynamic diameters for PEG-Phosphonate, PEG-COOH, and PEGNH2 particles also indicates that the particles may have excess ligands on the surface or
are agglomerating in solution. The larger uncertainty ranges of these particles indicate
that they are not very stable in water and are likely precipitating and agglomerating
during the measurements. Instability and unwanted surface charge of the nanoparticles
can have a negative impact depending on the desired application such as drug delivery.
Table 2.1. Hydrodynamic diameters and zeta potentials of the unlabeled and labeled modified
and unmodified nanoparticles.

Unlabeled
particles

Fe3O4oleic
acid np

PEGnDOPA
np

PEGDOPA
np

PEGPhosphonate
np

PEGCOOH
np

PEGNH2 np

Z-avg.
diameter
(nm)

35.4±4.3

90.3±5.2

84.7±3.2

203±12.7

220±14.3

176±10.1

Zeta
potential
(mV)

n/a

-6

-5

-15

-22

-23
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Labeled
particles

Fe3O4oleic
acid np

PEGnDOPA
np

PEGDOPA
np

PEGPhosphonate
np

PEGCOOH
np

PEGNH2 np

Effective
diameter
(nm)

41.2±5.4

100±7.1

89.1±5.1

214±11.5

232±15.2

184±11.6

Zeta
potential
(mV)

n/a

-7

-6

-18

-25

-24

2.3.3 TGA
TGA data yielded percent weight loss of material on the surface of the unlabeled, oleic
acid coated nanoparticles before and after dialysis and on the surface of unlabeled, PEG
coated nanoparticles after dialysis (Figures 2.13-2.16). These values were used to
calculate the grafting density of the ligands on the nanoparticles under the assumption
that only one type of ligand, PEG or oleic acid, was present on the surface of the
particles. Table 2.2 contains a summary of the data. The TGA data illustrates a trend
similar to the DLS data with the more stable particles (i.e. PEG-nDOPA and PEGDOPA) having a higher surface coverage than the PEG-COOH and PEG-NH2 particles.
Again, the calculations of surface coverage are made assuming that only 5000 g/mol PEG
is present on the modified particles. If the PEG-COOH and PEG-NH2 particles still have
a large amount of oleic acid on the surface relative to the amount of PEG chains, then this
assumption could explain why the calculated surface coverage values for these particles
are so low. The values were calculated using the larger molecular weight of the PEG and
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not the molecular weight of the oleic acid which would have yielded more reasonable
surface coverage values. The PEG-Phosphonate particles have a higher surface coverage
like the PEG-DOPA and PEG-nitroDOPA particles. However, the DLS and zeta values
for these particles may attribute this higher surface coverage to the presence of excess
ligand and a mix of oleic acid and PEG chains.
Table 2.2. Weight percent loss and corresponding grafting densities of nanoparticles obtained
from TGA analysis.

Np
Np
PEGPEGPEGPEG- PEGbefore
after nDOPA DOPA Phosphonate COOH NH2
dialysis dialysis
np
np
np
np
np
Weight loss
(%)

59.9

51.2

74.2

79.2

76.8

37.9

40.2

Surface
coverage
(chains/nm2)

29.1

20.4

3.16

4.18

3.65

0.67

0.74

LSC
corrected
surface
coverage
(chains/nm2)

n/a

n/a

3.13

4.16

3.60

0.61

0.70
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Figure 2.13. TGA curves of unlabeled, oleic acid coated nanoparticles a) before dialysis and b)
after dialysis in chloroform.
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Figure 2.14. TGA curves of unlabeled a) PEG-nitroDOPA modified nanoparticles and b) PEGDOPA modified nanoparticles.
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Figure 2.15. TGA curves of unlabeled a) PEG-phosphonate modified nanoparticles and b) PEGCOOH modified nanoparticles.
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Figure 2.16. TGA curve of unlabeled, PEG-amine modified nanoparticles.

2.3.4 VSM
VSM hysteresis loops of the unlabeled, oleic acid coated nanoparticles (Figure 2.17)
indicate the particles are magnetic with a saturation magnetization of approximately
66.85 emu/g of nanoparticles. This is within the range of 60-90 emu/g expected of
magnetite (Fe3O4) nanoparticles.142 The coercivity was found to be less than the accuracy
of the instrument indicating that there is little to no hysteresis in this sample at room
temperature.
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Figure 2.17. Hysteresis loop of the unlabeled nanoparticles. Magnetic moment is measured in SI
units of A*m2/kg of magnetite as determined by ICP-MS.

2.3.5 LSC
The amount of radiolabeled oleic acid in each sample was determined using LSC. The
data for each sample was normalized to the number of nanoparticles present in the sample
(based on determination of total Fe via ICP-MS), and the measured radioactivity was
used to ultimately calculate the amount of oleic acid present on the surface of the
particles before and after modification. The amount of oleic acid on the surface of the
oleic acid coated nanoparticles before and after dialysis and on the modified particles
after dialysis is shown in Figure 2.18. The results indicate a large amount or excess of
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oleic acid on the surface of the particles after dialysis and before modification. Dialysis
was not useful for removing much of this excess oleic acid as shown in the figure and
demonstrated by GPC (seen in a later section). Differences in surface coverage values
between TGA and LSC can be explained by differences between the batches of
nanoparticles synthesized. However, as expected the amount of oleic acid is dramatically
decreased on the particles that were modified indicating that ligand exchange took place.
The results show a trend that agrees with the TGA and DLS data. The PEG-nitroDOPA,
PEG-DOPA, and PEG-Phosphonate particles have lower amounts of oleic acid than the
PEG-COOH and PEG-NH2 particles signifying a more successful modification or ligand
exchange. This data reveals a hierarchy of binding of the functional groups to the surface
of magnetite. The catechol groups (i.e. nitroDOPA and DOPA) and the phosphonate
group bind and modify better than the carboxylic acid and the amine groups with no
statistical difference (two sample t-test, t(4)=1.44, α=0.05) between the amounts of oleic
acid remaining on the PEG-nitroDOPA and PEG-DOPA modified particles. This
relationship agrees with previous studies that show the ability to modify particles well
with catechol derived anchor groups.100, 103 The LSC data in combination with the TGA
results for the catechol-derived PEG ligands indicates greater displacement of the oleic
acid and increased surface coverage of the PEG on the nanoparticles.
The LSC results were used to adjust the TGA results of the unlabeled nanoparticles to
account for the oleic acid remaining on the surface after modification. Although TGA is
useful for determining the amount of ligand present on the surface, it does not
differentiate the types of ligands present. LSC is a sensitive technique and was used to
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counter the assumption that all of the ligand on the surface of the unlabeled particles was
PEG. The TGA values were corrected by subtracting the mass of oleic acid (as
determined from chains/nm2 by LSC) from the mass of organic material lost on the
nanoparticles by TGA. Specifically, the surface coverage values determined by LSC
were used to calculate the total number of oleic acid chains present on the total mass of
the unlabeled nanoparticles in each respective TGA sample. Dividing the number of
chains by Avogadro’s number yielded the moles of oleic acid, which when multiplied by
the molecular weight of oleic acid gave the amount of oleic acid in milligrams. That
mass of oleic acid was subtracted from the total mass of organic material on the
nanoparticles, and a new weight loss (%) was determined. From these new weight loss
values the corrected surface coverages were calculated using the previously described
TGA surface coverage calculations.
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Figure 2.18. Chains of oleic acid remaining on the surface of the nanoparticles before and after
ligand exchange determined by LSC. The data for the PEG coated nanoparticles represent the
amount of oleic acid remaining after dialysis.

Although the results in Table 2.3 reveal a very small scale change in surface coverage for
the nanoparticles, by comparison, the corrected values for the PEG-nitroDOPA and PEGDOPA particles reveal that the majority of the organic material present on the particles
was PEG. The corrected number of chains on the surface of the PEG-Phosphonate and
PEG-NH2 particles indicate a difference of 0.05-0.06 chains/nm2 from the original TGA
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surface coverage values. These values may seem small, but when applied to the bulk
nanoparticle solution these differences could have a significant effect on the particles due
to the inhomogeneity on the surfaces. Furthermore, the results indicate that all of the
organic material on the PEG-COOH coated particles is in fact oleic acid and not PEG.
Therefore, these particles would not be useful for any applications which require
dispersion into water. The use of the LSC results to adjust the TGA data emphasizes the
importance of this method for quantification and qualification of the ligand exchange.
Table 2.3. Weight percent loss and corresponding grafting densities of unlabeled, oleic acid
coated nanoparticles obtained from TGA analysis and LSC results for radiolabeled, oleic acid
coated nanoparticles to compare removal of excess oleic acid by dialysis and GPC.

Np before dialysis

Np after dialysis

Np through GPC
column

TGA Weight
loss (%)

59.9

51.2

35.8

TGA Surface
coverage
(chains/nm2)

29.1

20.4

10.8

LSC Surface
coverage
(chains/nm2)

20.6

16.0

12.1

2.3.6 GPC Column
The oleic acid coated, non-dialyzed nanoparticles were passed through a GPC column of
swollen beads in order to determine if the use of this method might successfully remove
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more excess oleic acid than purification or dialysis. The excess oleic acid on the particles
can contribute to agglomeration of the particles and may contribute to a slower rate of
ligand exchange. The particles were purified and dialyzed in chloroform to remove any
excess that may be present before modifying them by ligand exchange. However, as
shown in Figure 2.19a and 2.19b the dialysis did not remove much if any of the excess
ligand on the particles. The GPC column was used to compare methods and determine if
one might be more successful than the other.
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Figure 2.19. TGA curves of unlabeled, oleic acid coated iron oxide nanoparticles a) passed
through a GPC column and b) iron oleate precursor.

The TGA results reveal the presence of a large amount of oleic acid on the surface of the
particles before modification and little removal by dialysis. Furthermore, the TGA data
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reveals the presence and removal of iron oleate precursor in the nanoparticle solutions
before dialysis, after dialysis, and after the particles were passed through a GPC column
(Figures 2.13 and 2.19a). The weight loss or step transition that occurs between 200 and
300C for the nanoparticles before dialysis (Figure 2.13a) is similar to the transition seen
in TGA results of iron oleate (Figure 2.19b). The dialyzed nanoparticles show a
decreased transition in this region indicating that the removal of the undesired iron oleate
was successful during dialysis. The TGA curves and the data in Table 3 reveal the GPC
column was successful in removing iron oleate and a large amount of excess oleic acid on
the surface of the nanoparticles.
The TGA and LSC results of the particles passed through the GPC columns illustrate the
removal of a large amount of oleic acid on the surface of the as-synthesized
nanoparticles. The TGA results in Table 2.3 and Figure 2.19a reveal a large decrease
from 29.1 chains/nm2 to 10.8 chains/nm2 after the particles were passed through the GPC
column. The LSC results in Table 2.3 reveal a decrease of almost 50% in the oleic acid
chains covering the surface of the radiolabeled nanoparticles. The differences between
the amounts of oleic acid removed from the unlabeled and radiolabeled nanoparticles
passed through GPC columns can be attributed to the differences in the size and volumes
of the columns that the particles were passed through. The larger column that the
unlabeled nanoparticles were passed through allowed for more contact of the sample with
the beads and more removal of excess ligand. Overall, these results indicate that the GPC
column is a more effective method for removing excess, unwanted ligands on the surface
of the particles. This information implies the passing of the particles through the GPC
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column before ligand exchange may enhance the ligand exchange further by removing
excess material which may slow down the reaction time.
2.4 Conclusions
This study provides insight into the binding hierarchy of functional groups on the surface
of magnetite. LSC was used to track radiolabeled ligand on the surface of particles
thereby yielding information about the efficiency or success of modification of these
nanoparticles to make them suitable for certain applications. The trend shown in the data
agrees well with previous studies done with catechol derived anchor groups and other
functional groups attached to PEG chains. Unlike other commonly used methods, this
radiotracer method using 14C-oleic acid clearly indicates the presence of a specific ligand
on the surface of the nanoparticles and can be used to quantify the amount of that
material. The results showed that even the strongly binding catechol anchor groups
(DOPA and nitroDOPA) did not remove 100% of the oleic acid. Therefore, it is not
always safe to assume complete ligand exchange. Further investigation is necessary to
ensure a full modification of the nanoparticles so that they exhibit the desired properties
in appropriate environments. This method yielded information about the ligand
composition on the surfaces of the nanoparticles which affects their stability. This
method can be used to verify and even explain the results of other methods used to
characterize the ligand exchange on nanoparticles. Understanding more about the surface
chemistry of these nanoparticles can lead to better control in the applications of them.
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CHAPTER 3: DIRECT MEASUREMENT OF LIGAND EXCHANGE ON
IRON OXIDES WITH SMALL MOLECULE LIGANDS VIA
RADIOANALYTICAL TECHNIQUES
Reproduced with permission from [Davis, K.; Cole, B.; Ghelardini, M.; Powell, B. A.;
Mefford, O. T., Quantitative Measurement of Ligand Exchange with Small-Molecule
Ligands on Iron Oxide Nanoparticles via Radioanalytical Techniques. Langmuir 2016, 32
(51), 13716-13727.] Copyright [2016] American Chemical Society
3.1 Introduction
Ligand exchange using small molecules has been accomplished via different routes and
moieties. For instance, small molecule ligands may be used as linkers or starting
molecules for further modification.13, 143 In one such example, magnetite nanoparticles
were modified with (3-aminopropyl)triethoxysilane (APTES) to link to poly(ethylene
glycol) (PEG) chains to provide a suitable surface for MRI contrast agents.144 Small
molecule ligands may also be used to minimize size for different applications.145, 146
Portet et al. compared phosphate, phosphonate, sulfonate, and carboxylate functional
molecules in MRI contrast agents due to their reduced size for enhanced tissular diffusion
of nanoparticles.102 Results revealed that coating with bisphosphonate functional
molecules allowed for small, stable particles across a wide pH range (2.5-13).
Furthermore, competition-adsorption experiments indicated little desorption of the
bisphosphonate molecules and thus promise for future physiological studies.
Complete ligand exchange of these small molecules is necessary for peak performance of
the nanomaterials. However, accurate determination of ligand exchange completion can
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present a challenge. Previous attempts have been made to quantify ligand exchange of
these materials using techniques like FTIR,24, 147 TGA,15, 148 XPS,25, 122 UV-Vis,149, 150 and
photoluminescence spectroscopy.150, 151 Methods like these are common but may have
limitations and/or may not accurately represent the extent of exchange. In the previous
chapter, quantification of ligand exchange using sensitive, radioanalytical techniques
exposed incomplete reactions with hydrophilic polymer ligands. This chapter introduces
the utility of these radioanalytical techniques for quantification of ligand exchange with
small molecule ligands.152 The ligands were chosen based on head groups which are
commonly used to modify these materials, such as catechols,107 thiols,153 and silanes,154
carboxylic acids,89 sulfonates,102 and phosphonates (Figure 3.1).102

Figure 3.1. Schematic of ligand exchange with small molecule ligands bearing different head
groups.

Furthermore, these ligands were employed in exchange reactions using procedures which
have been previously reported and used by many other researchers. Table 3.1 contains 92
references for the previously reported ligand exchange procedures used for each of these
ligands as well as references of other works which cited the original procedure. The
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original procedures were shown to be useful for achieving what is claimed as complete
modification of the nanoparticles, and thus, have been continually employed in other
studies. However, the methods used to verify the exchange reactions may not have been
sensitive enough to detect residual oleic acid after exchange which resulted in inaccurate
representations of the success of the procedures and of the binding affinities of the anchor
groups. Furthermore, comparison of these techniques does not allow for determination of
a true binding hierarchy due to multiple uncontrolled exchange parameters. To overcome
this issue, a standardized ligand exchange protocol was used to establish a hierarchy of
the functional groups and to verify the success of the well established protocols.
Table 3.1. Ligand exchange procedures and references for the small molecule ligands.

Small molecule ligan d

Pr ocedur e Summar y

Refer ences

zwitterionic dopamine sulfonate

2-step ligand exchange: 1) 2[2-(2methoxyethoxy)ethoxy]acetic
acid in methanol reacted at
70°C for 5 hours 2)
zwitterionic dopamine
sulfonate in DMF/water
solution reacted at 70°C for
12 hours

145, 146, 155-164

nanoparticles and APTES in
toluene (6 ml) with 10 μl of
acetic acid; shaken for 72
hours at room temperature

3, 14, 17, 65, 66, 88, 91,

nanoparticles in toluene
exchanged with APTES in
water and triethylamine

12, 122, 131, 187

HO

N

SO3

HO

(3-aminopropyl)triethoxy silane
(APTES)
Procedure 1
O
O

Si

116, 165-186

NH2

O

(3-aminopropyl)triethoxy silane
(APTES)
Procedure 2

69

O

Si

O

(TEA) for 15 minutes at
room temperature

NH2

O

citric acid
O

OH

O

O

HO

OH
OH

1) meso-2,3-dimercaptosuccinic
acid
O

SH

nanoparticles in a 50:50
chlorobenzene and N,N’dimethylformamide solution
with citric acid, agitated at
100°C for 18 hours

13, 65, 67-69, 87, 181,

nanoparticles in toluene with
ligand in dimethylsulfoxide
stirred for 48 hours at room
temperature

74, 89, 90, 98, 200-206

caffeic acid/water solution
adjusted to pH 10 using
NaOH; solution added to
nanoparticles in hexane;
sonicated for 30 minutes and
stirred for 2 hours

88, 91, 92, 119, 207-214

nanoparticles and ligand
dispersed in THF, stirred for
24 hours under nitrogen at
reflux

215-218

188-199

OH
HO
SH

O

2) 2-mercaptoethanol
HO
SH

caffeic acid
O
OH
HO
OH

1) 2-aminoethyl phosphonic acid
O
HO

P
NH2
OH

2) (N,N-bis(phosphono methyl)
glycine)
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O
HO

P
O
OH
N
OH

HO

P

OH

O

3) taurine
O
S
HO

NH2
O

4) 3-(2-pyridyl0-5,6-di(2-furyl)1,2,4-triazine-5’,5’’-disulfonic
acid disodium salt
O
S
-

Na+

O
O

Na+

N

O

-

O

S

O

N
N

O
N

O

To quantify the extent of the exchange reactions radiolabeled iron oxide nanoparticles
were synthesized via thermal decomposition with 14C-oleic acid as a radiotracer. These
particles were modified with citric acid, caffeic acid, zwitterionic dopamine sulfonate,
dimercaptosuccinic acid (DMSA), (3-aminopropyl)triethoxysilane (APTES), 2mercaptoethanol, (N,N-bis(phosphono methyl) glycine), 2-aminoethyl phosphonic acid,
3-(2-pyridyl0-5,6-di(2-furyl)-1,2,4-triazine-5’,5’’-disulfonic acid disodium salt, and
taurine. The particles were modified via ligand exchange using the varied methods
referenced in table 3.1 and using a standardized exchange procedure. The particles were
purified and measured using liquid scintillation counting (LSC) to quantify the ligand
exchange. The particles were further characterized via TEM, DLS, ATR-FTIR, and VSM
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to determine size, hydrodynamic diameter and colloidal stability, qualify the
modifications, and verify the magnetic properties of the particles respectively.
3.2 Experimental
3.2.1 Materials
Iron (III) acetylacetonate (99%) was purchased from Strem Chemical. Ethanol
(anhydrous, histological grade), acetone (99.9%), ammonium hydroxide (29 wt%), and
methanol (laboratory grade) were purchased from Fisher Chemical. Oleic acid (90%),
iodomethane (99+%) and 1,3-propanesultone (99%) were purchased from Alfa Aesar. 3aminopropyltriethoxysilane (APTES; 99%), taurine (99%), 2-aminoethyl phosphonic
acid (99%) and N,N-dimethylformamide (anhydrous, 99.8%) were purchased from
Acros Organics. N, N-bis(phosphonomethyl)glycine (>98%) was purchased from Aldrich
Chemistry. Citric acid (>99.5%), 2-mercaptoethanol (≥99%), dopamine hydrochloride,
sodium carbonate (≥99.99%) and 3-(2-pyridyl0-5,6-di(2-furyl)-1,2,4-triazine-5’,5’’disulfonic acid disodium salt were purchased from Sigma Aldrich. Caffeic acid (3,4dihydroxy cinnamic acid) and meso-2,3-dimercaptosuccinic acid (>98%) were purchased
from Tokyo Chemical Industry (TCI). Toluene (>99.5%) and tetrahydrofuran (99%)
were purchased from BDH Chemicals. Bio-Beads™ S-X1 Support (200-400 mesh) were
purchased from Bio-Rad. [2-(2-methoxy)ethoxy] acetic acid was purchased from EMD
Millipore. Hexanes were purchased from BD Chemical. Optiphase Ultima Gold AB
liquid scintillation cocktail and oleic acid [1-14C] (>97%) were purchased from
PerkinElmer.
3.2.2 Radiolabeled Nanoparticle Synthesis
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Magnetite (Fe3O4) nanoparticles were synthesized via a method previously reported by
Vreeland et al.44 In order to synthesize radiolabeled nanoparticles with a target diameter
of 20 nm 1.074 g (3.04 mmol) of iron (III) acetylacetonate, 13.305 g (47.1 mmol) of oleic
acid, and 1 μCi of 14C-oleic acid were added to a 3-necked round-bottom flask. The flask
was placed in a metal bath containing a low melting point metal alloy which allows for
good thermal control. The reaction was heated to 200°C and purged with nitrogen. The
nitrogen was passed through bubblers to prevent the release of radiolabeled materials.
The solution in the flask was stirred using an overhead stirrer at 400 rpm. After the
solution stirred for 10 minutes it was heated to 350°C for 3.5 hours.
The nanoparticles were purified by dispersion in 5 ml of hexane and addition of 15 ml of
ethanol and 25 ml of acetone. The solution was shaken, the particles were separated
using a magnet, and the remaining solvents were poured off. This process was repeated
two more times to ensure removal of excess oleic acid. The particles were further
purified by passage through a gel permeation chromatography (GPC) column containing
styrene-divinylbenzene copolymer beads.15, 139 The beads were swollen in toluene
overnight and poured into a burette to pack the column with the gel. A concentrated
sample of nanoparticles in toluene was added to the top of the column and collected at the
bottom as a dark band.
3.2.3 Synthesis of Zwitterionic Dopamine Sulfonate
Zwitterionic dopamine sulfonate was prepared using a previously reported method
(Figure 3.2).145 Dopamine hydrochloride (6 mmol) was dissolved in 150 ml of ethanol in
a 500 ml round-bottom flask. The flask was purged with nitrogen while 28% ammonium
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hydroxide (3 mmol) and 1,3-propanesultone (6.5 mmol) were slowly added to the flask.
The solution was heated to 50°C and stirred for 18 hours. The resulting precipitate was
filtered and washed with ethanol three times. The product, dopamine sulfonate, was
dried in a vacuum oven and stored for further analysis and use. NMR was used to verify
synthesis of the dopamine sulfonate by peaks at 6.6-6.8 ppm (aromatic -CH), and 3.25
ppm (-CH2-S-) (Figure 3.3).

Figure 3.2. Reaction scheme for synthesis of zwitterionic dopamine sulfonate.

Dopamine sulfonate (1 mmol) was dissolved in 150 ml of dimethylformamide (DMF) in
a 500 ml round-bottom flask. Anhydrous sodium carbonate (2.4 mmol) was added to the
solution as it stirred via magnetic stir bar. The flask was purged with nitrogen, followed
by the addition of iodomethane (35 mmol). The solution was stirred for 10 hours at
50°C. To precipitate the product, ethyl acetate was added to the solution in a 1:10 v/v
ratio. The product was filtered and 50 ml DMF/acetone (1:10 v/v) was added to the
product and refluxed at 55°C for 2 hours. The solution was filtered and precipitate
collected. This process was repeated two more times. The final product was dried in a
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vacuum oven for future analysis and use. NMR was used to verify synthesis of the
zwitterionic dopamine sulfonate by peaks at 6.6-6.8 ppm (aromatic -CH), 3.25 ppm (CH2-S-), and ~3.12 ppm (CH3-N+-).

Figure 3.3. NMR spectra of a) dopamine sulfonate and b) zwitterionic dopamine sulfonate.

3.2.4 Ligand Exchange with Zwitterionic Dopamine Sulfonate
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According to a previously reported procedure the nanoparticles were modified via a twostep ligand exchange.145 The oleic acid was first exchanged with 2-[2-(2-methoxyethoxy)
ethoxy] acetic acid in methanol at 70C for 5 hours. Second, this ligand was replaced
with the zwitterionic dopamine sulfonate in a DMF/water solution at 70C for 12 hours.
The particles from the first reaction were purified by addition of acetone and hexane to
precipitate the product and centrifugation at 10,000 rpm for 5 minutes to isolate the
particles. The resulting product from the second reaction was purified by addition of
acetone to precipitate the particles and centrifugation at 10,000 rpm for 5 minutes to
isolate the particles. These particles were then dispersed into DI water.
3.2.5 Ligand Exchange with APTES (Procedure 1)
The surfaces of the nanoparticles were modified via ligand exchange using a combination
of two procedures with some variation.116, 165 The nanoparticles (50 mg) were dispersed
in toluene (6 ml) and combined with APTES (1.5 ml). The particles were shaken on a
shake plate for 72 hours at ambient conditions. The particles were separated using a
magnet and washed three times using hexanes to remove excess ligands. The particles
were dispersed in DI water for further characterization.
3.2.6 Ligand Exchange with APTES (Procedure 2)
Nanoparticles were modified via ligand exchange with APTES according to a previous
procedure.122 The nanoparticles were dispersed in toluene (50 ml). The nanoparticle
solution, 5 ml of TEA, and 1 ml of distilled water were added to a 100 ml, three-neck,
round flask under nitrogen flow and mechanical stirring. 5 ml of APTES was added as

76

the solution stirred for 15 minutes. The resulting particles were purified by several
washes in toluene and dispersed into DI water.
3.2.7 Ligand Exchange with Citric Acid
Nanoparticles were modified with citric acid using a previously reported procedure for
ligand exchange.65 120 mg of dried nanoparticles were dispersed in 15 ml of a 50:50
mixture of chlorobenzene and N,N’-dimethylformamide and mixed with 0.1 g of citric
acid. The mixture was agitated at 100°C for 18 hours. The particles were precipitated in
diethyl ether and collected by magnetic separation. The particles were redispersed in
acetone and recovered again by magnetic separation three times. The particles were dried
with nitrogen to remove acetone then dispersed in water.
3.2.8 Ligand Exchange with DMSA and 2-mercaptoethanol
According to a previously reported procedure nanoparticles were modified with DMSA
via ligand exchange.89 The same procedure was used to modify the particles with 2mercaptoethanol. The synthesized nanoparticles were dispersed in 80 ml of toluene and
added to a solution of DMSA in dimethyl sulfoxide (DMSO; 20 ml). The mixture was
stirred for 48 hours, and the DMSA coated nanoparticles precipitated during the reaction.
The supernatant was removed and the particles were washed with ethanol and redispersed
in water. Sodium hydroxide was then added to increase the pH to ~10. The resulting
black, homogeneous dispersion was dialyzed for 3 days, filtered (0.22 µm) and pH
adjusted to 7.
3.2.9 Ligand Exchange with Caffeic Acid
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Ligand exchange with caffeic acid was performed according to a previously reported
procedure by de Montferrand et al.92 One ml of an aqueous caffeic acid solution was
adjusted at pH 10 using NaOH solution (10-1 mol/L). This solution was added to 1 ml of
the hydrophobic nanoparticles dispersed in cyclohexane. The mixture was sonicated for
30 minutes then stirred for 2 hours. The organic, non-polar surfactant was diluted by
adding 2 ml of cyclohexane, followed with centrifugation. The supernatant was
discarded and the resulting particles were water dispersible.
3.2.10 Ligand Exchange with Phosphonate and Sulfonate Head Groups
According to a previously reported procedure by Lartigue et al., nanoparticles were
modified with (N,N-bis(phosphono methyl) glycine) and 2-aminoethyl phosphonic
acid.215 Modifications with 3-(2-pyridyl0-5,6-di(2-furyl)-1,2,4-triazine-5’,5’’-disulfonic
acid disodium salt and taurine were performed using the same procedure. The
nanoparticles were dispersed in tetrahydrofuran and mixed with the hydrophilic ligands.
The mixture was stirred under nitrogen for 24 hours at reflux. Pentane was added to the
solution to precipitate and the sample was centrifuged. The product was redispersed,
precipitated with ethanol, and centrifuged again to isolate the particles. The final product
was dispersed into DI water.
3.2.11 Standardized Ligand Exchange
Ligand exchange reactions with all of the small molecule ligands were performed again
using a more standardized method. The particles and ligands were mixed together in
homogeneous solutions and allowed to react on a shake plate at ambient conditions for
three days. To prepare ligand exchange reactions 5 mg of the nanoparticles were
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dispersed in 8 ml of either THF or toluene and combined with the 100 mg of the ligands
dispersed in either water, toluene, or DMSO. The phosphonate and sulfonate-containing
ligands, citric acid, and ZDS were dispersed in 2 ml of DI water. The caffeic acid was
dispersed in 2 ml of water and the pH was adjusted to 10 using NaOH (10-1 mol/L) in
order to solubilize the ligand. DMSA and 2-mercaptoethanol were prepared by
dispersion in 2 ml of DMSO, and APTES was prepared by dispersion into 2 ml of
toluene. The reaction solutions were agitated on a shake plate for 3 days, collected via
magnetic separation and centrifugation, dried and redispersed in water. The particles that
were successfully dispersed into water were used for further analysis.
3.2.12 Characterization
TEM was used to determine the core diameter of the nanoparticles and to compare aged
particles. The samples were prepared by dilution of the nanoparticle solutions and
application of the solutions to copper grids with carbon mesh. TEM images were
obtained using a Hitachi H7600 TEM with an accelerating voltage of 120 kV. Image
analysis to determine particle size and distribution was performed using Image J.
TGA was used to determine surface coverage of the oleic acid on the nanoparticles. 5 to
10 mg of each sample was placed in the TGA pan, which was analyzed using a TA
Instruments 2950 TGA. The samples were heated at 20°C/minute under nitrogen purge
to 110°C, held at 110°C for 30 minutes, then heated at 15°C/minute to 800°C. According
to a previously reported procedure the weight percent loss of organic material was used in
a series of calculations to determine the oleic acid surface coverage of the particles.15
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To determine the iron concentrations of each individual aliquot removed during the aging
study ICP-MS was performed using a ThermoScientific XSeries 2 ICP-MS. The
concentrated HNO3 used to digest the samples was evaporated and the samples were
dispersed in 10 ml of a 2% solution of nitric acid in DI water. The samples were
measured using 45Sc as an internal standard.
DLS and zeta potential measurements were performed to determine hydrodynamic
diameter and surface potential of the unmodified and modified nanoparticles. The
nanoparticle solutions were diluted with water or hexane and put into a cuvette or a zeta
cell. Each unlabeled sample was measured three times at 25 °C using a Malvern
Zetasizer Nano ZS to determine the intensity average size distribution, z-average
diameter, and the zeta potential. The labeled particles were measured three times at 25°C
using a Brookhaven 90Plus with ZetaPALS to determine size distribution, effective
diameter, and zeta potential. A study by de Jaeger et al. showed that both of these
instruments report the same average diameter of the particles.140
ATR-FTIR was performed to qualitatively analyze the nanoparticles after modification.
This technique was used to confirm the presence of the hydrophilic ligands after
exchange. The nanoparticle samples were dried to remove water and/or solvent before
measurement. The samples were measured using a Thermo Fisher Scientific Nicolet
FTIR with ATR attachment and a diamond ATR crystal.
VSM was used to analyze the magnetic properties of the samples. The samples were
prepared by adding a few drops of nanoparticle solution onto the end of a cotton swab.
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The samples were analyzed at 300K in a 3T field with a Quantum Design VSM which
runs on the physical property measurement system 6000 (PPMS 6000).
LSC was utilized to determine the amount of 14C-oleic acid contained in the nanoparticle
samples separated from each aliquot solution. A 150 μl aliquot of each nanoparticle
sample in 2% HNO3 was added to scintillation cocktail in 20 ml scintillation vials. The
samples and background samples were counted for 30 minutes using a PerkinElmer
TriCarb 2910 TR LSC instrument. The results, reported in counts per minute (cpm),
were used to calculate the moles of oleic acid per milliliter of solution using Equation
2.1.
3.3 Results and Discussion
Nanoparticles were synthesized via thermal decomposition, modified via widely reported
ligand exchange procedures and via a standardized procedure. The particles were
purified and dispersed into water. The particles were characterized to determine size,
hydrodynamic diameter, zeta potential, and magnetic properties, then subsequently
analyzed by LSC to quantify the amount of radioactive oleic acid present on the surface
of the particles after ligand exchange.
Some samples dispersed into water more easily than others, and all exchanges resulted in
a large quantity of particles which would not disperse into water at all. The amount of
particles that did not transfer to water from all of the reactions ranged from 75-98% of the
initial particle samples. This indicates that regardless of the reaction parameters, ligand
exchange does not result in high yields. Furthermore, a large number of particles and
polymer must be used to insure collection of sufficient quantities of modified particles for
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desired applications. Quantitative investigation of ligand exchange could lead to
improvement of these reactions and increased yields.
3.3.1 TEM
The unlabeled and radiolabeled nanoparticles were imaged using TEM. (Figure 3.4)
Analysis of the TEM images using ImageJ revealed a size distribution of 17.1 nm ± 1.8
for the unlabeled particles and 17.8 ± 1.9 for the radiolabeled nanoparticles. These
values are statistically different per a two-tailed t-test (p<0.0001). The particles were
synthesized via two different reactions so the sizes were not expected to be the same.
The sizes, determined from the average surface areas, were used in the calculations to
determine the amount of ligand present on the surface of the nanoparticles.

Figure 3.4. TEM images (left) and histograms (right) of the unlabeled nanoparticles (a) and the
radiolabeled nanoparticles (c).
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3.3.2 DLS
The hydrodynamic diameters and zeta potentials of the nanoparticles were measured
using DLS. This yielded information about the stability of the particles before and after
modification with the small molecule ligands. Table 3.2 shows the results of the
nanoparticles modified using varied exchange protocols. Comparison of results between
the oleic acid-coated particles and the modified particles reveals a decrease in
hydrodynamic diameter for some of the samples modified with smaller ligands. The zeta
potential values of the DMSA, APTES, bisphosphonate, and disulfonate-coated particles
are around ±30 mV which indicates moderate to good colloidal stability relative to the
less stable (between -30 and 30 mV) taurine, 2-aminoethyl phosphonic acid, and 2mercaptoethanol coated particles.219 This trend corresponds with the increase in standard
deviations of the hydrodynamic diameters of the less stable particles. The ZDS modified
particles appear to be colloidally stable with a zeta potential close to zero due to the
electrically neutral quality of the ligand. Table 3.3 contains the results of the
nanoparticles modified using a standardized exchange procedure. The results are in good
agreement with those previously discussed (Table 3.2). The zeta potential values of the
APTES, caffeic acid, and citric acid modified nanoparticles in Table 3.3 indicate an
increase in stability (i.e. more positive or more negative) as compared to those in Table
3.2. This is likely due to the different reaction parameters. The longer exchange time
used for the standardized procedure may have allowed for increased modification (i.e.,
increased ligand exchange), and thus, improved colloidal stability.
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Table 3.2. DLS size and zeta results of nanoparticles modified using varied procedures.

Unlab eled
par ticles

Z-avg.
diameter
(nm)

Zeta
potential
(mV)

Lab eled
par ticles

Effective
diameter
(nm)

Zeta
potential
(mV)

oleic acid

36±3

n/a

oleic acid

38±2

n/a

ZDS

35±2

-1

ZDS

37±3

-2

APTES

39±4

31

APTES

35±5

34

citric acid

27±5

-27

citric acid

29±4

-25

DMSA

28±2

-35

DMSA

30±3

-37

2mercaptoethanol

33±7

10

2mercaptoethanol

35±8

13

caffeic acid

25±2

-33

caffeic acid

23±3

-36

2-aminoethyl
phosphonic acid

31±5

-12

2-aminoethyl
phosphonic acid

34±4

-15

bisphosphonic
acid

30±2

-31

bisphosphonate

34±2

-32

taurine

29±7

-16

taurine

32±6

-19

disulfonate

50±4

35

disulfonate

55±5

32

Table 3.3. DLS size and zeta results of nanoparticles modified using a standardized procedure.

Unlab eled
par ticles

Z-avg.
diameter
(nm)

Zeta
potential
(mV)

Lab eled
par ticles

Effective
diameter
(nm)

Zeta
potential
(mV)

oleic acid

36±3

n/a

oleic acid

38±2

n/a

ZDS

32±2

-1

ZDS

34±2

-1

APTES

33±3

34

APTES

31±2

35

citric acid

24±3

-33

citric acid

25±4

-30

DMSA

30±3

-32

DMSA

33±4

-35

84

2mercaptoethanol

34±6

14

2mercaptoethanol

37±7

17

caffeic acid

26±2

-36

caffeic acid

24±2

-37

2-aminoethyl
phosphonic acid

28±4

-11

2-aminoethyl
phosphonic acid

30±5

-13

bisphosphonic
acid

33±2

-30

bisphosphonate

37±3

-34

taurine

35±6

-13

taurine

37±5

-14

disulfonate

54±4

33

disulfonate

57±4

34

3.3.3 ATR-FTIR
ATR-FTIR was used to qualify the modifications of the nanoparticles. The results are
shown in Table 3.4. These results correspond to the spectra illustrated in Figures 3.53.10. The tables contain significant peaks that indicate the presence of the specific
ligands on the surface of the particles. However, the spectral results also indicate the
presence of oleic acid remaining on some of the particles. The results of the particles
modified with APTES using a varied protocol indicate the presence of oleic acid with a
peak at 1693 cm-1. Results of the particles modified with taurine and 2-mercaptoethanol
using both the individual procedures and the standardized procedure also indicate the
presence of oleic acid remaining bound to the surface of the particles with peaks
occurring around 1520-1540 cm-1. This correlates with the DLS data and could explain
the colloidal instability of these particles. The results of the particles modified using
varied procedures compare well with the results of those modified using a standardized
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procedure. The ATR-FTIR results are only qualitative and must be used in combination
with a quantitative method to confirm exchange.
Table 3.4. ATR-FTIR results of nanoparticles modified using previously reported procedures
and a standardized procedure.

Small molecule ligan d

Charac ter istic peaks (cm -1) for r efer enced
pr ocedur es
Characteristic peaks (cm-1) for standardized
procedure

ZDS

1693-1407 (ar omatic C=C bend ing), 887-640
(ar omati c C-H b ending), 1033 an d 943 (S-O-R),
1149 (S=O)
1600-1398 (aromatic C=C bending), 900-595
(aromatic C-H bending), 1037 and 942 (S-O-R), 1151
(S=O)

APTES

1076 (Si-O-R), 929 (C-N)
1092 (Si-O-R), 917 (C-N)

citric acid

1740 an d 1697 (C=O str etch), 1139 (alk oxy C-O)
1732 and 1691 (C=O stretch), 1152 (alkoxy C-O)

DMSA

2445 an d 2528 (-SH), 1704 (C=O str etch)
2547 (-SH), 1700 (C=O stretch)

2-mercaptoethanol

1045 (C-S str etch)
1036 (C-S stretch)

caffeic acid

1336 (ph enol C-O), 1552 (ar omati c C=C bending),
883-640 (ar omatic C-H bending)
1328 (phenol C-O), 1569 (aromatic C=C bending),
890-656 (aromatic C-H bending)

2-aminoethyl phosphonic acid

1641 (N-H b end), 1068 (C-N), 1133 (P=O), 2850
((O=)PO-H)
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1628 (N-H bend), 1073 (C-N), 1123 (P=O), 2845
((O=)PO-H)
bisphosphonate

1712 (C=O str etch), 1126 (P=O), 2805 ((O=)PO-H
1703 (C=O stretch), 1137 (P=O), 2810 ((O=)PO-H

taurine

1168 an d 1200 (S=O), 1033 an d 962 (S-O-R), 1612
(N-H b end)
1156 and 1205 (S=O), 1028 and 956 (S-O-R), 1620
(N-H bend)

disulfonate

1480 an d 1570 (N=N), 1700-1600 (C=N str etch),
1600-1410 (C=C bending), 1040 an d 937 (S-O-R),
1200 (S=O)
1490 and 1576 (N=N), 1701-1610 (C=N stretch),
1598-1423 (C=C bending), 1041 and 946 (S-O-R),
1207 (S=O)

Figure 3.5. ATR-FTIR spectra of nanoparticles modified using previously reported procedures
for 2-aminoethylphosphonic acid, 2-mercaptoethanol, and APTES.
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Figure 3.6. ATR-FTIR spectra of nanoparticles modified using previously reported procedures
for caffeic acid, the bisphosphonate ligand, and citric acid.

Figure 3.7. ATR-FTIR spectra of nanoparticles modified using previously reported procedures
for the disulfonate ligand, ZDS, taurine, and DMSA.

88

Figure 3.8. ATR-FTIR spectra of nanoparticles modified using a standardized procedure for
DMSA, 2-aminoethylphosphonic acid, and citric acid.

Figure 3.9. ATR-FTIR spectra of nanoparticles modified using a standardized procedure for the
disulfonate ligand, the bisphosphonate ligand, and caffeic acid.
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Figure 3.10. ATR-FTIR spectra of nanoparticles modified using a standardized procedure for
APTES, taurine, 2-mercaptoethanol, and ZDS.

3.3.4 VSM
VSM was used to verify that the unlabeled particles were magnetic. The results in Figure
3.11 show a saturation magnetization of 40 emu/g. This value is lower than that of bulk
magnetite, but comparable to values previously reported for these materials.165, 220 The
particles were measured well after they were synthesized and stored in solvent which
may have evaporated resulting in some oxidation of the particles over time and a decrease
in the saturation magnetization.
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Figure 3.11. VSM hysteresis loop of oleic acid coated, unlabeled nanoparticles.

3.3.5 LSC
The amount of radiolabeled oleic acid remaining after ligand exchange for each sample
was determined using LSC. The results for each sample were normalized to the total
nanoparticle concentrations of each (based on determination of total Fe via ICP-MS).
The measured activity of each sample was used to calculate the total amount of oleic acid
remaining on the particles after exchange using the aforementioned equation. The results
of the exchange reactions using previously reported procedures are shown in Figure 3.12.
Although these results are not definitive of a hierarchy of binding moieties, they do
indicate effects of binding group and reaction conditions on exchange. Results indicate
that the catechol groups (i.e. caffeic acid and ZDS) displaced the greatest amount of oleic
acid. This agrees with other reports of catechols binding well and with great affinity to
iron oxides.15, 107 Furthermore, the bifunctional sulfonate and phosphonate binding
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moieties displaced more oleic acid than their monofunctional counterparts. The
procedures used for the sulfonate and phosphonate ligands were the same, so these results
suggest that multidentate ligands bind more robustly than monodentate ligands. This
finding agrees well with previous studies investigating multidenticity of ligands.99, 138
Comparison of results of the APTES ligand exchange reactions illustrates that increased
reaction time (72 hours) and use of a catalyst (acetic acid) enhanced the displacement of
oleic acid greatly. A longer reaction time allows the exchange to approach equilibrium,
and a catalyst serves to speed up the reaction; therefore, it is understandable that this
procedure was more successful than the 15 minute procedure. Ultimately, these results
do not indicate a true binding hierarchy as there are multiple factors which are
uncontrolled including the length of the exchange, multidenticity of the anchoring group,
solvent conditions, temperature, and presence of catalyst. This is evidenced by the
different procedures used for the APTES ligand. Therefore, it was important to further
investigate using a standardized procedure to isolate binding affinity as a contributing
factor. The standardized procedure allowed for uniform time of exchange, uniform
temperature, and use of homogeneous solvent conditions so that the uncontrolled factor
was binding moiety. Therefore, a binding hierarchy could be determined and the
previously published procedures could be verified.
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Figure 3.12. Results of ligand exchange reactions using previously reported methods and a
standardized procedure.

The results of the modifications using a standardized procedure are shown in Figure 3.12.
The standardized procedure allowed for exclusion of other factors, which may contribute
to the binding trend. These results reveal a binding hierarchy with catechols displacing
the most oleic acid and 2-mercaptoethanol and taurine displacing significantly less than
the other ligands. This agrees with the results of the aforementioned ligand exchange
reactions thus confirming the robust anchoring of catechols to iron oxide surfaces. The
amount of oleic acid remaining after exchange with taurine using the standardized
procedure is higher (~0.9 chains/nm2) than the amount left after exchange using the
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previously reported procedure (~0.6 chains/nm2). The differences between these results
may be explained by the use of heat and nitrogen by the previously prescribed procedure
to catalyze the reaction and prevent oxidation, respectively. Again, it can be seen that the
bifunctional sulfonate and phosphonate moieties displaced more oleic acid than the
monofunctional phosphonate and sulfonate indicating more effective binding with
multidentate ligands. APTES, citric acid, and DMSA displaced a significant amount of
oleic acid resulting in particles which were colloidally stable as indicated by DLS. The
results of the APTES and DMSA exchanges using a standard procedure compare well to
the use of previously reported methods indicating that variations in reaction parameters
did not strongly affect the binding of the ligands. These ligands appear to bind rather
robustly to iron oxides regardless of conditions. This is evidenced by the extensive use of
these materials to modify iron oxide nanoparticles as indicated in Table 3.1. Finally,
increased exchange of citric acid using a standardized procedure compared to the
prescribed procedure could possibly be explained by the extended reaction time of the
standardized procedure.
Overall, these results show that choice of binding moiety can greatly affect the success of
a ligand exchange reaction. Furthermore, even when using a binding moiety with high
affinity for iron oxide, there can still be oleic acid remaining after ligand exchange.
Therefore, it is prudent to thoroughly characterize the particles before and after to ensure
optimal surface coverage for the desired application. These findings also suggest the
importance of reaction reagents, conditions, and parameters. Extending ligand exchange
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reaction time and controlling reaction conditions (i.e. catalysts, pH, temperature,
stirring/agitation, etc.) may be necessary to optimize the exchange.
3.4 Conclusions
This investigation resulted in sensitive measurement of ligand exchange with small
molecule ligands bearing different binding groups under varied reaction conditions. LSC
was used to determine the activity of 14C in each of the samples after exchange, and
ultimately, calculate the amount of oleic acid remaining after ligand exchange.
Characterization of the unlabeled nanoparticles via DLS and ATR-FTIR confirmed trends
observed with LSC. Despite the reaction conditions, catechols displaced more oleic acid
compared to the other binding groups. However, even the catechols did not displace
100% of the oleic acid. Bifunctional ligands coated the particles more completely than
monofunctional ligands illustrating the robust quality of multidentate ligands.
Furthermore, comparison of the procedures used for the APTES ligand and comparison
of the varied procedures and standardized procedure revealed the importance of
extending reaction time and use of catalysts to enhance the reaction. Overall, this study
allows insight into the manipulation of surface chemistry of these materials and the
importance of thorough examination after modification to achieve optimal quantity and
quality of the product.
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CHAPTER 4: THE EFFECT OF POST-SYNTHESIS AGING ON THE
LIGAND EXCHANGE ACTIVITY OF IRON OXIDE NANOPARTICLES
4.1 Introduction
Magnetic nanoparticles hold great promise as a material for applications ranging from
biomedical applications such as therapeutics and imaging to environmental remediation.13, 5-8

These applications would not be possible without robust methods to modify the

surface of these materials. One widely used method to alter the surface properties and
tailor the surface of metal and metal oxide nanoparticles is ligand exchange. The rate of
the ligand exchange can be altered by the structure of the nanoparticle surface including
such features as edges, grain boundaries, and defect sites. This structure creates different
electron densities and steric accessibilities that affect ligand exchange rates.221-223 As
nanoparticles age these edge effects and defect sites may be subject to change.
Furthermore, as iron oxides age they may oxidize from magnetite to maghemite.
Oxidation state of iron can affect the binding of certain ligands as evidenced in a study by
Amstad et al.103 In this study they found that nitrocatechols bind preferentially to Fe2+
before binding to Fe3+. To the best of the authors knowledge, relatively little research has
quantified the effects of iron oxide aging on ligand exchange.
Nonetheless, other metal and metal oxide based nanoparticles have shown appreciable
decreases in properties due to aging of their surfaces. Gradual decreases in the ligand
exchange reactivity224 and electrocatalytic activity225 of gold nanoparticles have been
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connected to this surface aging phenomena. Disulfides have been shown to displace short
chained thiols at a slower rate when the gold nanoparticles were aged in chlorobenzene
solution due to thiol stabilization of defect sites.224 Aging has also been revealed to have
effects on various properties of metal oxides. It has been shown that aging of copper
manganese oxides affects the catalytic activity of these materials. For example, copper
manganese oxides were prepared by a hydrolysis-coprecipitation method and aged for
20-72 hours post-synthesis.226 The aged oxides were compared to unaged oxides in a
catalytic CO oxidation study. Results showed an increase in catalytic activity with aging
due to formation of less-crystallized phases and an increase in surface area during the
aging process. Aging of cobalt ferrite nanoparticles was shown to improve crystallinity
of the core material,227 where the properties of surface-passivated and nonpassivated
particles were aged at low pH. This caused the formation of an amorphous, iron-rich
outer layer and increased the crystallinity of the core. The changes resulted from
increased dissolution of the cobalt cations during the passivation process and replacement
of those ions with iron cations, thus modifying the Fe/Co cation distribution which
altered the magnetic properties of the particles.

Dissolution is a time-evolved concern

with other iron oxide materials as well.228, 229 One study found that dissolution of these
materials is “controlled by the coordinative arrangements around the metal centers in the
surface lattice.”228 Therefore, the ligands bound to the surface affect the dissolution of
these materials. It was found that binuclear surface complexes formed by phosphate,
arsenate, borate, and sulfate are good at inhibiting dissolution of iron oxides. In short,

97

there is a strong correlation in aging effects on the structural and crystalline properties of
these materials, which in turn could affect binding of ligands to their surfaces.
To better understand these relationships, we developed a methodology to quantify the
effects of aging on ligand exchange of iron oxide nanoparticles. Nanoparticles were
synthesized via thermal decomposition with oleic acid as a stabilizing ligand. The
nanoparticles were then mixed with varying concentrations of 14C-labeled oleic acid at
either 2, 7, or 30 days following synthesis. To measure the kinetics of exchange at the
three different aging times, aliquots of the nanoparticle solutions were collected and the
particles were isolated at various time points after exposure to the radiolabeled oleic acid.
Liquid scintillation counting (LSC) was used to measure the activity of the samples and
calculate the amount of 14C-oleic acid chains present on the nanoparticles in each aliquot.
Results of the aging study were further analyzed to elucidate kinetics of the reaction. A
follow-up study was done to isolate the effects of oxidation, which can occur over time.
In this study, nanoparticles were synthesized via thermal decomposition, and half of the
reaction volume was oxidized in air for 15 minutes at 175°C. Mössbauer spectroscopy
was utilized to quantify the oxidation of the particles using this procedure. Aliquots of
the nanoparticle solutions (oxidized and unoxidized) were collected at various time points
during ligand exchange with 14C-oleic acid and measured using LSC.
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4.2 Experimental
4.2.1 Materials
Iron (III) acetylacetonate (99%) was purchased from Strem Chemical. Ethanol
(anhydrous, histological grade) and acetone (99.9%) were purchased from Fisher
Chemical. Oleic acid (90%) was purchased from Alfa Aesar. Hexanes (≥98.5%) were
purchased from EMD Millipore. Bio-Beads™ SX-1 support (styrene-divinylbenzene
copolymer beads) were purchased from Bio-Rad Laboratories, Inc. Optiphase Ultima
Gold AB liquid scintillation cocktail and oleic acid [1-14C] (>97%) were purchased from
PerkinElmer. Toluene (99.5%) was purchased from BDH Chemicals.
4.2.2 Nanoparticle Synthesis
Iron oxide nanoparticles were synthesized via a method previously reported by Vreeland
et al.44 To synthesize nanoparticles with a target diameter of 20 nm 1.074 g (3.04 mmol)
of iron (III) acetylacetonate and 13.305 g (47.1 mmol) of oleic acid were added to a 3necked round-bottom flask. The flask was placed in a metal bath heated to 200°C and
purged with nitrogen. The solution in the flask was stirred using an overhead stirrer at
400 rpm. After the solution stirred for 10 minutes it was heated to 350°C for 3.5 hours.
The nanoparticles were purified by dispersion in 5 ml of hexane and addition of 15 ml of
ethanol and 25 ml of acetone. The solution was shaken, the particles were separated
using a handheld magnet, and the remaining solvents were decanted. This process was
repeated two more times to ensure removal of excess oleic acid. The particles were
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further purified by passage through a gel permeation chromatography (GPC) column
containing styrene-divinyl benzene copolymer beads.139 The beads were swollen in
toluene overnight and poured into a burette to pack the column with the gel. A
concentrated sample of nanoparticles in toluene was added to the top of the column and
collected at the bottom as a dark band.
4.2.3 Aging Study
The nanoparticle solutions (20 nm target diameter; ~2 mg/ml of Fe3O4) aged for 2, 7, and
30 days were exposed to solutions of 14C-oleic acid in toluene. The aging was conducted
by storing the particles in toluene in a sealed scintillation vial at room temperature.
Aliquots of these solutions were collected and analyzed at different time points to
observe effects of aging on ligand exchange. As stated above, the concentration of the
stock solution of 14C-oleic acid as determined by liquid scintillation counting was
414,908 dpm/ml. To create solutions of varying molar concentrations of 14C-oleic acid,
216.9 μl, 433.8 μl, and 650.7 μl of the stock solution were combined with unlabeled oleic
acid and added to the nanoparticle suspensions to obtain 5000 dpm/ml (3.6×10-11
mol/ml), 10000 dpm/ml (7.2×10-11 mol/ml), and 15000 dpm/ml (1×10-10 mol/ml)
solutions, respectively. The particle suspensions were placed on a shake plate for
approximately 0.5 minutes, 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 10
hours, 12 hours, 16 hours, 24 hours, and 32 hours before 1 ml aliquots were removed
from the solutions and put into 15 ml centrifuge tubes. The aliquots were mixed with 2
ml of ethanol and 2 ml of acetone to separate the excess oleic acid from the particles then
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centrifuged at 9,500 rpm for 10 minutes to insure separation. The supernatant from each
tube was removed and placed into separate centrifuge tubes for further analysis. After
measurement and analysis of the samples it was determined that the particles should be
further purified via passage through a GPC column as previously described. The
particles were passed through the column once, and then smaller aliquots were passed
through a syringe column (20 ml syringe) containing the same copolymer beads in
toluene. The syringe column was plugged with glass wool to prevent the beads from
escaping.
4.2.4 Kinetic Modelling
Modelling of the reaction kinetics was used to determine changes in rate constants with
respect to aging time. Initial attempts at fitting the adsorption data to first order rate
equations did not work as that approach did not account for the reversible adsorption.
Modelling was based on a simplified reversible, first order reaction where one labeled
oleic acid displaces one unlabeled oleic acid on the surface of the particles described by
the equation below:

Eq. 4.1) [14OA] + [OA-np] ↔ [14OA-np] + [OA]
where [14OA] is the concentration of the free 14C-oleic acid in the liquid, [OA-np] is the
concentration of the oleic acid bound to the nanoparticles, [14OA-np] is the 14C-oleic acid
bound to the nanoparticles, [OA] is the unlabeled oleic acid coming off the particles, and
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the reaction order is 1 with respect to the concentrations. The rate of change of 14C-oleic
acid in the liquid phase can be written as:

Eq. 4.2)

d[14OA]
dt

= -k f [14OA]+k r [14OA-np]

Where kf is the forward rate constant removing 14C-oleic acid from the liquid phase by
exchange with stable oleic acid on the nanoparticle surfaces and kr is the desorption rate
of 14C-oleic acid from the nanoparticle surface. Note for convenience [14OA-np] is
written as a liquid phase concentration above to keep the rate constants with the same
units but conversion to solid phase concentrations can easily be done by multiplying by
the nanoparticle suspension concentration. At time zero, the concentration of 14C-oleic
acid on the nanoparticle surface is zero (i.e., [14OA-np] = 0 at time zero). Therefore, the
concentration of [14OA-np] can be written as:
Eq. 4.3) [14OA-np] = [14OA]0 – [14OA]t
Where [14OA]0 is the concentration of 14C-oleic acid in the liquid phase at time zero and
[14OA]t is the concentration of 14C-oleic acid in the liquid phase at time t. Equations 4.2
and 4.3 can be combined to express the reaction rate in terms of the liquid concentration
of 14C-oleic acid.

Eq. 4.4)

d[14OA]
dt

= (k f +k r )[14OA]t+k r [14OA]0
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At equilibrium where the left hand side of equation 4.4 is equal to zero, the equilibrium
concentration of aqueous 14C-oleic acid can be written as:
k

r
Eq. 4.5) [14OA]eq= k +k
[14OA]0
f

r

Combining equations 4.4 and 4.5 and integrating yields:
Eq. 4.6) [14OA]t=[14OA]eq+ c1 e-(kf +kr)t
Finally applying the initial condition that [14OA]t = [14OA]0 at t = 0 to determine c1, the
final analytical solution in equation 4.7 can be determined.
Eq. 4.7) [14OA] = [14OA]eq + ([14OA]0 − [14OA]eq)𝑒 −(𝑘𝑓 +𝑘𝑟 )𝑡
Rearranging the terms and taking the natural log of each side yields the linear expression
shown below:
[14OA]−[14OA]eq

Eq. 4.8) ln [14OA] −[14OA] = -(kf-kr)t
0

eq

where the overall reaction rate constant (kf-kr) is the slope and the y-intercept is zero.
The data was plotted in this linear form and analyzed using regression analysis to
determine the overall slope. The linear expression (Eq. 4.8) was used to model the loss of
14

C-oleic acid from the liquid phase as it sorbed onto the particles as a function of time.

The average slope (i.e. overall rate constant) of the plots for each data set was used to
plot a model for each. Noting that the data shown below plateaus after > 30 hours, the
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final measured aqueous concentration of 14C-oleic acid was used as the input value for
[14OA]eq. Modelling the ligand concentration on the nanoparticle surface (which was also
measured to monitor conservation of mass) required the assumption that for one ligand to
adsorb another ligand must desorb. This may not be an accurate description of the
exchange observed. Modelling the decrease in ligand concentration from the solution as
the ligands adsorb to the particles does not utilize this assumption, and therefore, may be
more accurate.
4.2.5 Oxidation Study
Iron oxide nanoparticles with a target diameter of 20 nm were again synthesized
according to the previously stated procedure. To oxidize the particles following particle
synthesis in a controlled manner, approximately half of the resulting product was
oxidized by mechanically stirring at 155°C for 15 minutes in open air. The unoxidized
half was allowed to cool to room temperature under nitrogen. Both of the resulting
suspensions of nanoparticles (i.e., unoxidized and oxidized) were purified by dispersion
in 5 ml of hexane and addition of 15 ml of ethanol and 25 ml of acetone. The suspension
was shaken, the particles were separated using a handheld magnet, and the remaining
solvents were decanted. This process was repeated five more times to insure removal of
the majority of excess oleic acid. Washes 4-6 for the oxidized particles were performed
using centrifugation (8000 rpm for 10 minutes) to isolate the particles to prevent loss of
material due to the diminished magnetic response. The particles were dispersed in
toluene and a solution of oleic acid combined with 14C-oleic acid as a radiotracer in
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toluene (1 mol:1 mol of oleic acid to oleic acid initially present in the nanoparticle
suspensions). Aliquots were collected, purified, and measured as previously described.
4.2.6 Characterization
Transmission electron microscopy (TEM) was used to determine the core diameter of the
nanoparticles and to compare aged particles. The samples were prepared by dilution of
the nanoparticle suspensions and application to copper grids with a carbon mesh. TEM
images were obtained using a Hitachi H7600 TEM with an accelerating voltage of 120
kV. Image analysis to determine particle size and distribution was performed using
ImageJ (National Institutes of Health).
Ultraviolet-visible (UV-VIS) spectroscopic measurements were performed to determine
concentration of iron in the nanoparticle suspensions before addition of radiolabeled
material.44 Approximately 5-10 μl of each magnetite sample were digested in 0.2 ml of
concentrated hydrochloric acid (37%, HCl) at room temperature for 5 minutes. The
dissolved iron was then diluted to 10 ml with deionized (DI) water and 0.5, 1.0, 1.5, 2,
and 2.5 ml of the HCl/water solutions were pipetted into two separate 15 ml centrifuge
tubes. DI water was added to each tube to dilute the solutions to 7 ml followed by
addition of 0.2 ml of hydroxylamine hydrochloride aqueous solution (100 g/l), 0.5 ml of
1,10-phenanthroline aqueous solution (3 g/l), and 1.0 ml of an aqueous solution of
sodium acetate and acetic acid (200 g/l and 100 g/l, respectively) were added to the
centrifuge tubes. Upon addition of these reagents a pink color developed in the solution
due to the coordination complex formed by the phenanthroline with iron. The absorbance

105

of these solutions was then obtained by a PerkinElmer UV/Vis/NIR Spectrometer
Lambda 950. The absorbance values were compared to known standards and used to
calculate the corresponding gram amounts of iron in the two magnetite samples. The
molar relationship between iron and magnetite was then used to find the gram amount of
magnetite in the two samples.
Thermogravimetric analysis (TGA) was used to determine surface coverage of the oleic
acid on the nanoparticles. 5 to 10 mg of each sample was placed in TGA pan, which was
analyzed using a TA Instruments 2950 TGA. The samples were heated at 20 °C/minute
under nitrogen purge to 110 °C, held at 110 °C for 30 minutes, then heated at 15
°C/minute to 800 °C. According to a previously reported procedure the weight percent
loss of organic material was used in a series of calculation to determine the oleic acid
surface coverage of the particles.15
Inductively coupled plasma mass spectrometry (ICP-MS) was used to determine the iron
concentrations of each individual aliquot removed during the aging study. The
concentrated HNO3 used to digest the samples was evaporated and the samples were
dispersed in 10 ml of a 2% HNO3/DI water solution. The samples were measured using
a ThermoScientific MS XSeries 2 ICP-MS.
Liquid scintillation counting (LSC) was utilized to determine the amount of 14C-oleic
acid contained in the nanoparticle samples separated from each aliquot solution. 150 μl
of each nanoparticle sample in 2% HNO3 was added to scintillation cocktail in 20 ml
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scintillation vials. The samples and background samples were counted for 30 minutes
using a PerkinElmer TriCarb 2910 TR LSC instrument. LSC and ICP-MS results were
used to calculate the amount of oleic acid remaining on the particles after modification
according to a previously reported procedure.15 The resulting counts per minute (cpm)
were used to calculate moles of oleic acid per milliliter of solution using the equation
below:

Eq. 4.9)

moles 14C
ml

=

sample cpm-background cpm
counting efficiency
ln(2)
×(6.022×1023 )×ml
t 1/2

where the numerator represents decays per minute (dpm), the counting efficiency is
0.931, and the denominator is the decay constant ((λ) 2.3x10-10 min.-1) multiplied by
Avogadro’s number and the number of milliliters of the LSC sample. The half-life (t1/2)
of 14C is 5,730 years. The molar ratio of unlabeled oleic acid to 14C-oleic acid was used
to determine the overall amount of oleic acid ligands exchanged onto the nanoparticles.
Mössbauer spectroscopic measurements were first conducted of two samples labelled
oxidized and non-oxidized at UNCA’s Materials Research Group Laboratory. Each
sample received of colloidal suspension containing oleic acid coated iron-oxide
nanoparticles was condensed by volatilization of hexanes. The condensed material was
loaded into cylindrical polylactide (PLA) containers to a 3 mm depth. Prepared samples
in containers were placed in a linear alignment with the oscillating 57Cobalt gamma
source and the detector. Mossbauer spectra were recorded in the temperature range 11 K
< T < 293 K using a Wissel spectrometer in constant acceleration mode with 57Co source
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in Rh matrix. Low temperature measurements were taken by placing the sample in a
helium 4 K Cryostat (Advanced Research Systems, Inc.) Temperature probes were placed
in the heat column and at the perimeter of the plastic sample container. Fitment was
recorded in terms of isomer shift (𝛿), quadrupole splitting, magnetic hyperfine field
(Heff), line width, component area and a statistical criterion (χ2). Instrumental error for
the velocity scale or spectral point +/- 0.5 channel. Reference signal was folded against a
standard α-Fe foil absorber at 295K to determine zero shift and optimal peak width.
Vibrating sample magnetometry (VSM) was used to analyze the magnetic properties of
the samples. The samples were prepared by adding a few drops of nanoparticle solution
onto the end of a cotton swab. The samples were analyzed at 300K in a 3T field with a
Quantum Design VSM which runs on the physical property measurement system 6000
(PPMS 6000).
4.3 Results and Discussion
Aging Study
Iron oxide nanoparticles were synthesized via thermal decomposition, aged in toluene for
2, 7, and 30 days. The particles were characterized to determine size, size distribution,
ligand surface coverage, and magnetic properties. The particles were employed in ligand
exchange reactions with oleic acid and 14C-oleic acid. Aliquots were collected
throughout the reactions to monitor the exchange with time of reaction. The particles
were characterized to determine size and size distribution, ligand surface coverage, and
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magnetic properties. The aliquots were analyzed by LSC to determine the amount of
radiolabeled oleic acid present on the surface and in solution (i.e. the supernatant) after
exchange. Modelling of the reactions was used to determine kinetic parameters of the
ligand adsorption. The results are provided in greater detail below.
4.3.1 TEM (Aging Study)
The synthesized particles were characterized via TEM to determine the particle size
distribution. Analysis of the TEM images using ImageJ yielded size distributions (Figure
4.1) of the nanoparticles used in the initial aging study and in the oxidation study. The
average diameter of the particles used in the aging study was 17.4 nm with a standard
deviation of 1.56. The particles were analyzed via TEM after aging for 7 days and 30
days in toluene to verify that there were no changes in size or morphology due to aging.
The particles which were aged for 7 days were on average 17.3 nm with a standard
deviation of 1.53 and no significant size difference from the synthesized particles (aged 2
days) (unpaired t-test, p=0.4283). The particles which were aged for 30 days were 17.2
nm with a standard deviation of 1.57 and no significant size difference from the
synthesized particles (aged 2 days) (unpaired t-test, p=0.1181).
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Figure 4.1. TEM image (above) and histogram of size distribution (below) of different aged
nanoparticles. a) nanoparticles aged 2 days. b) nanoparticles aged 7 days. c) nanoparticles aged
30 days.

4.3.2 TGA (Aging Study)
The size results were further used to determine ligand surface coverage before
modification via TGA. TGA results yielded percent weight loss of organic material on
the surface of the nanoparticles before modification (Figure 4.2). Analysis of the data
revealed an 85% weight loss between 200-500°C of the organic material on the
nanoparticles synthesized and purified for use in the aging study (Table 4.1). This
corresponds to a high surface coverage of approximately 180 chains/nm2. The particles
were further purified through a GPC column to remove the excess ligand. Further
purification reduced the amount of organic material to approximately 48 chains/nm2.
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Although the surface coverage was still high, further purification may have resulted in
destabilization of the particles.14

Figure 4.2. TGA of aging study nanoparticles after initial purification.
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Figure 4.3. TGA of aging study nanoparticles after GPC purification.
Table 4.1. TGA results and surface coverages of nanoparticles used for aging study.

Before GPC

After GPC

Weight loss (%)

85

63

Surface coverage
(chains/nm2)

180

62

4.3.3 VSM (Aging Study)
VSM was used to observe the magnetic properties of the particles used for the aging
study. The data was normalized to the iron content in grams which was determined using
UV-Vis. The results are shown in Figure 4.4. The graph reveals a saturation
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magnetization of 40 emu/g. This value is lower than that of bulk magnetite, but it
compares well to other values reported in literature.165, 220 The particles were measured
well after they were synthesized and employed in the aging study. Loss of solvent during
storage and oxidation may have contributed to a decrease in the saturation magnetization.

Figure 4.4. VSM results of nanoparticles used for aging study.

4.3.4 LSC (Aging Study)
The amount of radiolabeled oleic acid in each sample was determined using LSC. The
data for each sample was normalized to the amount of nanoparticles present in the sample
(based on determination of total iron via ICP-MS). The results were used to calculate the
amount of radiolabeled oleic acid exchanged onto the surface of the nanoparticles and the
amount of radiolabeled ligand remaining free in solution. The results from measurements
of the initially cleaned particles (i.e. not purified via a GPC column) were used to
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determine the overall amount of oleic acid on the particles and are shown in Figure 4.5.
The graph illustrates a large amount of oleic acid on the particles at a 1:1 molar ratio of
oleic acid. Additionally, there is some amount of newly introduced oleic acid present on
the particles at the onset of the experiment. This seemed unlikely, therefore, the particles
were further purified via passage through a GPC column and a syringe column to better
remove the excess, unbound oleic acid. The results of the measurements after further
purification are shown in Figure 4.6. The figure depicts a more accurate representation
of the radiolabeled oleic acid present on the particles during the exchange reactions with
2 day, 7 day, and 30 day aged particles. Further cleaning of the particles decreased the
amount of oleic acid on the particles and resulted in fewer outlying data points.

Figure 4.5. Amount of oleic acid (unlabeled and labeled) on the particles during exchange at
different aging times and at a 1:1 molar ratio of oleic acid.
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Figure 4.6. Amount of oleic acid exchanged on the 2 days (a), 7 days (b), and 30 days (c) aged
nanoparticles at all molar ratios and first-order fits to data. Green lines represent the 1:1 molar
ratio, blue is 2:1 molar ratio, and red is the 3:1 molar ratio.

The final results of the ligand exchange reactions of different aged particles are shown in
Figure 4.7 and Figure 4.8. The graphs show a decrease in the concentration of
radiolabeled oleic acid in the solution which corresponds to an increase in radiolabeled
ligands adsorbing onto the surface. The decreases in concentration eventually plateau to
a relatively constant concentration indicating an approach to equilibrium. The results
revealed the changes in concentration of the ligands free in solution for each molar ratio
are closely proportional to the increase in the initial concentration of oleic acid for all
samples regardless of age. This indicates that no matter the core particle properties,
addition of more ligand is a driving force in the exchange reaction (e.g., considering Le
Chatelier's principle applied to equation 1). It is noteworthy that in Eq. 1 14C-oleic acid
was used to track the behavior of all oleic acid (14C labeled and stable) initially in the
liquid phase. Results also revealed a large decrease in free ligand concentration after the
particles were aged in toluene for 30 days. The aging process, between 7 and 30 days,
allowed for increased extent of adsorption. As discussed below, we hypothesize this is
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due to the presence of more available binding sites as the surface of the particles have
become more oxidized.

Figure 4.7. Amount of 14C-oleic acid in solution during exchange with the 2 days, 7 days, and 30
days aged nanoparticles at a 1:1 molar ratio and model fits to the data.
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Figure 4.8. Amount of 14C-oleic acid in solution during exchange with the 2 days, 7 days, and 30
days aged nanoparticles at a 2:1 and 3:1 molar ratio and model fits to the data.

4.3.5 Kinetic Modelling
The results as determined from LSC measurements were initially fit to models using
differential equations to describe the forward and reverse reactions, or adsorption and
desorption, and assuming first order kinetics. Non-linear regression analysis in Excel and
the use of Excel solver allowed for modelling of the adsorption kinetics on the particle
surface. The results are shown in Figure 4.6. This approach required the assumption that
a single ligand was displaced by a single incoming ligand. Modelling the kinetics of loss
of the oleic acid from the solution was used to avoid this assumption. In this approach,
the data was fit to models using a linearized analytical solution and regression analysis.
The kinetic analysis produced overall rate constants for the reversible reactions at 2 days,
7 days, and 30 days and yielded further insight into the true impact of aging on ligand
exchange reactivity of oleic acid. Results in Figure 4.7 and Figure 4.8 illustrate the good
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fit of the analytical solution to the experimental data. The similar trends and fits of the
curves for each molar ratio indicate the reaction is first order and is independent of
concentration. The linearized models (based on regression analysis) in Figure 4.9 and
Figure 4.10 show a reasonably good fit to the linearized data. The changes in the slopes
of the models directly correlates to the changes in overall rate constants shown in Table
4.2. This is illustrated in Equation 8, where the slope (i.e. overall rate constant) is the
difference between the forward and reverse rate constants. The plots indicate a slow
reaction which begins to level off after 10 hours. This time scale is large (on the order of
hours) relative to the reaction rates observed with aged gold nanoparticles (on the order
of minutes).224 This could be due to the fact that the reactions are not competitive
exchange reactions. This could also indicate slower adsorption due to some physical
barrier close to the particle surface.
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Figure 4.9. Linearized analytical solutions for 2 days, 7 days, and 30 days aged particles at a 1:1
molar ratio and the model fits based on linear regression analysis.

Figure 4.10. Linearized analytical solutions for 2 days, 7 days, and 30 days aged particles at a 2:1
and 3:1 molar ratio and the model fits based on linear regression analysis.
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Table 4.2. Rate constants from exchange reactions as determined from modelling.

Rate constant

2 days

7 days

30 days

4.4±0.3

4.2±0.2

3.6±0.4

(sec.-1 x 10-5)

The rate constants decrease with particle age, and the difference in the 2 day and 30 day
constants is statistically significant as determined using an unpaired t-test (p=0.0470,
α=0.05) (Figure 4.11). However, the differences between the 2 day and 7 day constants
and the 7 day and 30 day constants are not significant according to unpaired t-tests
(α=0.05, p=0.64 and p=0.08 respectively). This indicates that the difference between the
forward and reverse rate constants is decreasing with particle age, and thus, the forward
and reverse constants are becoming more similar. This could indicate an increase in the
desorption rate with aging, assuming the forward rate (adsorption) does not change. This
finding and the increase in the number of ligands leaving the liquid phase suggest a
change at the surface of the particles has allowed for a larger mass of ligands to adsorb.
The model does not yield unique solutions for the forward and reverse constants.
Therefore, other possible explanations could be a decrease in the forward rate constant
with an unchanging reverse constant or changes in both the forward and reverse rate
constants resulting in increased similarity of the values. Overall, a change in ligand
exchange reactivity with aging was observed, and further investigation was necessary to
elucidate a reason or cause for these behaviors.
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Figure 4.11. Average, overall rate constants for particles aged for 2 days, 7 days, and 30 days.

Oxidation Study
In a follow-up study of oxidation effects on exchange, nanoparticles were synthesized via
thermal decomposition, and half of the resulting product was controllably oxidized. The
unoxidized and oxidized particles were employed in ligand exchange reactions with oleic
acid and 14C-oleic acid and aliquots were collected throughout the reaction. Again, the
particles were characterized as described in detail below to determine size and size
distribution, surface coverage of the ligands, and the magnetic properties. LSC was used
to determine the amount of radiolabeled oleic acid present on the particles after exchange
to address the effects of oxidation on extent of the reaction.
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4.3.6 TEM (Oxidation Study)
The nanoparticles used in the oxidation study were measured with TEM before and after
oxidation to ensure no changes in morphology and/or size occurred due to the oxidation
process (Figure 4.12). Image analysis revealed no significant change with the unoxidized
particles having an average diameter of 19.4 nm with a standard deviation of 1.56 and the
oxidized particles having an average diameter of 19.3 nm with a standard deviation of
1.48 (unpaired t-test, p=0.4209). These findings agree with image analysis results from
the aging study. Oxidation during aging does not yield changes in morphology or size
which can be detected using standard TEM.

Figure 4.12. TEM images (above) and histograms of size distributions (below) of a) unoxidized
and b) oxidized nanoparticles.
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4.3.7 TGA (Oxidation Study)
TGA was used to determine surface coverage of the oleic acid on the unoxidized and
oxidized particles before ligand exchange. The results yielded percent weight loss of
organic material on the surface of the particles before modification (Figures 4.13 and
4.14). Analysis of the results of the unoxidized and oxidized nanoparticles revealed
similar surface coverages of 62 chains/nm2 and 57 chains/nm2 (Table 4.3). Again,
although the surface coverages were high, care was taken to not destabilize the particles
through further purification.

Figure 4.13. TGA results of unoxidized nanoparticles.
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Figure 4.14. TGA results of oxidized nanoparticles.
Table 4.3. TGA results and surface coverages of unoxidized and oxidized nanoparticles.

Unoxidized

Oxidized

Weight (%)

63

62

Surface coverage
(chains/nm2)

60

58

4.3.8 LSC (Oxidation Study)
As previously mentioned, oxidation can affect ligand binding due to preferential binding
of certain functional groups to different oxidation states of iron.103 Furthermore, it is well
known that oxidation of magnetite results in the formation of maghemite, and thus a

124

change in the ratio of Fe2+ and Fe3+.230-233 Therefore, in order to investigate this
phenomena, nanoparticles were synthesized, oxidized post-synthesis, and employed in a
ligand exchange reaction with 14C-oleic acid. Results of the adsorption of 14C-oleic acid
onto the particle surface are shown in Figure 4.15. The results reveal an increase in the
amount of oleic acid present on the particles with oxidation This is in agreement with
the results in Figure 4.16. This graph indicates that less 14C-oleic acid is in solution after
exchange with oxidized nanoparticles compared to the unoxidized nanoparticles, and
thus, more ligands adsorbed onto the oxidized particles. This finding suggests that
oxidation during the aging process may be a reason for the observed increase in ligand
adsorption. Wang and coworkers concluded that oxide shells, formed from oxidation of
iron nanoparticles, are defective which creates reactive sites and alters the chemical
reactivity of the surface.234 This could explain the increased availability of binding sites
with aging/oxidation. Moreover, formation of defects at the surface could impact ligand
binding, which in turn could influence spin canting and the magnetic properties of the
particles.235, 236 Further characterization of the particle surface structure and oxide shell
formation with aging would be necessary to confirm this reasoning. Overall, oxidation of
the core could occur during the shelf-life of nanoparticles intended for various
applications which could result in decreased stability of the particles depending on the
ligand bound or it could promote ligand exchange once the particles are introduced into a
competitive environment. Ligand exchange and/or instability of the particles could result
in a drastic change of behavior of the particles and thus, an ineffectiveness for many
applications.
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Figure 4.15. Adsorption of 14C-oleic acid onto the oxidized and unoxidized nanoparticles.

Figure 4.16. Loss of 14C-oleic acid from the solution during exchange with the unoxidized and
oxidized nanoparticles.
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4.3.9 Mössbauer Spectroscopy
While fitting the spectra the following components were identified (Table 4.4): two Fe3+
in tetrahedral sites (A1, A2), three Fe3+ in octahedral sites of non-disturbed nature (B30,
B31, B32), two Fe3+ in octahedral sites affected by neighboring vacancies (B33, B34),
Fe2+ in a non-disturbed octahedral site (B22), two Fe2+ octahedral sites with vacancy
defects in the next nearest environment (B23, B24) and paramagnetic Fe2+ low spin state
(LOS). Tetrahedrally coordinated sites show smaller values of isomer shifts (IS)
compared to octahedral sites. Hyperfine field on Fe3+ nuclei in non-disturbed octahedral
sites are highest in hematite and lowest in magnetite. Fe2+ shows hyperfine field lower by
100 kOe compared to Fe3+ because of the corresponding spin values 4/2 and 5/2.
Therefore Fe2+ can be differentiated from Fe3+ if the Mössbauer spectra obtained as
components are resolved in the fitting result.
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Table 4.4. Results of fitted Mössbauer spectra. The table contains values for the isomeric shift
(IS), hyperfine interactions (HI), and the quadrupole splitting (QS).

IS
(mm/s)

HI
(kOe)

QS
(mm/s)

Fe3+(A1)

0.32

523

0.03

Fe3+(A2)

0.31

504

0.03

Fe3+(B30)

0.51

545

-0.09

Fe3+(B31)

0.52

528

-0.02

Fe3+(B32)

0.51

506

-0.12

Fe3+(B33)

0.55

480

0.08

Fe3+(B34)

0.57

455

0.11

Fe2+(B22)

1.1

440

-0.10

Fe2+(B23)

1.1

420

-0.08

Fe2+(B24)

1.1

390

-0.11

Fe2+(LOS)

0.10

0

0.65

The coated nanoparticles (oxidized and unoxidized) provided for analysis were found to
have iron oxide cores that are comprised principally of magnetite, maghemite and
hematite phases (Table 4.5). The samples that were not oxidized demonstrated a
moderate amount of ideal magnetite phase included. Evidence of the Verwey transition in
nano-crystalline magnetite in nonstoichiometric nanometric powders were demonstrated
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and are evidenced as likely in literature.237 The presence of magnetite in the unoxidized
sample was confirmed by the Verwey transition being evident below 150K. When these
particles were heated in oxidative conditions they were found to be comprised of mostly
maghemite and little or no magnetite, or other oxides are observed. However, no iron
was identified as magnetically ordered Fe2+ at 11 K which strongly suggests no ideal
magnetite exists in the oxidized material. In general, core particles are composed of
nano-sized crystallites (grains) of different phases of maghemite or magnetite solid
solution with a possibility of less complex structured mineral (hematite or other inverse
spinel) with a possible variable volume ratio from particle to particle. Signals appearing
as Fe2+ doublets (i.e. paramagnetic material) could be unreacted reagent, surface
interacting iron, or an iron complexed with carbon chain byproduct, as it may also
interact with the pi bond of an olefinic acid’s carbon chain or alkane fragment during the
synthesis.
Table 4.5. Compositions of representative oxidized and unoxidized nanoparticle samples as
determine by Mössbauer spectroscopy.

α-Hematite

γ-Maghemite

Magnetite

Fe3O4 (%)

Fe3-xO4 (%)

Fe2O3 (%)

oxidized

10

87

0

3

unoxidized

18

63

16

3

Sample
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Other (%)

Figure 4.17. Mössbauer spectral results of the unoxidized (b, c, and e) and the oxidized (a, d, f, g,
and h) particles at 12 K.

130

Figure 4.18. Mössbauer spectral results of unoxidized (a and c) and oxidized (b, d, e, and f)
samples at 300 K.

4.3.10 VSM (Oxidation Study)
VSM was used to observe changes in the magnetic behavior of the particles with
oxidation. Results are shown in Figures 4.19 and 4.20. Results show a high saturation
magnetization of 70 emu/g for the unoxidzed nanoparticles. However, the saturation
magnetization of the oxidized particles is low at 27 emu/g. This is to be expected for the
oxidized sample as bulk maghemite has a lower saturation magnetization than bulk
magnetite. This further confirms that oxidation is the reason for the lower saturation
magnetization of the particles used for the aging study. The difference in values between
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the aging study particles and the oxidized particles could indicate a greater extent of
oxidation during the oxidation procedure.

Figure 4.19. VSM results of the unoxidized nanoparticles.
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Figure 4.20. VSM results of the oxidized nanoparticles.

4.4 Conclusions
Radioanalytical techniques were successfully used to monitor the effects of aging on
ligand exchange of iron oxide nanoparticles. The investigation revealed that aging of the
particles results in oxidation which yields an increase of 14C-oleic acid ligands adsorbed
onto the particles. Mössbauer spectroscopy, used to confirm the composition of the
oxidized and unoxidized nanoparticles, illustrated the oxidized particles are almost
entirely maghemite. VSM results agree with this finding as evidenced by the decrease in
saturation magnetization of the samples. Kinetic analysis of the results was used to
determine how aging affected the overall rate of the reaction. The overall rate constants
decreased with particle age, and the change in the constants from 2 to 30 days was
significant. The results suggest the formation of a defective surface and an increase in
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reactive sites occurs with oxidation which allows for more ligands to bind to the surface.
The decrease in rate constants could be related to the larger mass of ligands adsorbing
onto the particles or the reasoning may be more complex. This change occurs after a
week of storage indicating that shelf-life of these materials could greatly impact the
surface chemistry and thus, the stability of these particles. Furthermore, introduction of
aged particles into a more competitive environment could result in a change of surface
chemistry depending on the affinity of the anchor group for the aged surface. This would
largely affect the performance of the particles for a desired application. Further
investigation of aging impacts on particle surface structure, stability, and binding affinity
and binding constants of various head groups could yield a more definitive understanding
of the observed phenomena.
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CHAPTER 5: CONCLUSIONS
The surface modification of iron oxide nanoparticles via ligand exchange and the factors
which affect exchange were investigated and quantified in this work. Radioanalytical
techniques demonstrated to be a useful tool for measuring ligand exchange with
polymeric ligands and small molecule ligands. Liquid scintillation counting was used in
combination with other common characterization methods to thoroughly quantify and
qualify exchange on the surface of these materials. Furthermore, these techniques
provided insight into the effects of binding group chemistry, reaction conditions,
multidenticity, and nanoparticle aging and oxidation on extent and kinetics of ligand
exchange.
In Chapter 2 radiolabeled, iron oxide nanoparticles were synthesized using 14C-oleic acid
as a radiotracer. The particles were modified post-synthesis with PEG ligands bearing
different functional groups which are often used to bind and modify the surface of these
materials. LSC measurements before and after modification of the particles revealed the
extent of the exchanges and a binding hierarchy with catechols displacing the greatest
amount of oleic acid during exchange. Furthermore, use of LSC exposed the pitfalls of
other techniques like TGA to accurately quantify ligand exchange. Thorough
characterization is necessary to understand the exchange process and optimize the
polymer-particle systems for desired applications.
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Chapter 3 revealed an expansion of these studies through inclusion of additional binding
groups, comparison of reaction parameters like time, and comparison of monodentate and
multidentate ligands. This work explored ligand exchange with some commonly used
small molecule ligands bearing different functional groups and compared the
corresponding exchange procedures for those ligands with a standardized procedure.
LSC and FTIR measurements were used to observe increases in displacement of oleic
acid with multidentate ligands bearing sulfonate and phosphonate groups and an increase
in APTES ligands exchanged with increased reaction time. Furthermore, use of a
standardized exchange procedure allowed for establishment of a binding hierarchy in
which, again, catechols displaced the most oleic acid. These findings illustrate the
complexity of ligand exchange and the importance of optimizing the many factors which
influence it.
In Chapter 4, the effects of the core nanoparticle properties on surface chemistry were
investigated. Oleic acid coated, iron oxide nanoparticles were aged in solution for up to
30 days and exposed to a solution of additional oleic acid containing 14C-oleic acid as a
radiotracer. LSC measurements of aliquots taken throughout the duration of the
exchange reactions revealed an increase in the amount of 14C-oleic acid exchanged onto
the surface of the particles with particle age. Kinetic analysis of the data revealed a
decrease in the adsorption rate and an increase in the desorption rate with aging.
However, the change in the overall rate was not greatly affected by aging. Further
investigation revealed oxidation of the particles, which occurs over aging time, led to an
increase in the amount of radiolabeled ligands on the particles. These combined results
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suggest an increased availability of reactive sites or binding sites with oxidation, possibly
because of increasing defective nature of the core shell structure. Further studies of core
shell structure, colloidal stability, and binding affinity of various head groups could
elucidate a more definitive mechanism.
Overall, this work encompasses a review of our current understanding of ligand exchange
of nanomaterials and establishes the utility of radioanalytical techniques to sensitively
quantify the effects of various factors which influence ligand exchange. There are many
variables to consider when modifying the surfaces of these materials. Good control of
these parameters is critical to designing the ideal particle for the application. A thorough
understanding of these parameters is necessary to achieve this goal.
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CHAPTER 6: FUTURE WORK
This research yielded a better understanding of ligand exchange of iron oxide
nanoparticles as it relates to binding group chemistry, aging of the particle core, and some
reaction conditions. However, there are many other factors which affect ligand
exchange. These factors could be thoroughly investigated and quantified via
radioanalytical methods in combination with other specialized methods for determination
of binding affinities and colloidal stability. Furthermore, synthesis and use of
radiolabeled polymers would allow for further investigation of ligand structure effects on
exchange. These methods could be applied to the study of other particle and biological
systems.
6.1 Factors Affecting Ligand Exchange
This work has proven that radioanalytical methods are useful for sensitive quantification
and monitoring of ligand exchange. There are many factors which remain to be
investigated using these techniques. Temperature, ionic strength, pH, chain length, and
tail group chemistry have all been shown to impact ligand exchange of nanomaterials.18,
238-240

Nanoparticle environment effects like pH and ionic strength are particularly

interesting as these factors are very relevant to biological applications of iron oxides.
Iron oxide nanoparticles are often dispersed in biological media or buffers for biological
applications or research. The ability of the ligands to bind and stabilize the particles in
these conditions is very important. Optimizing the pH of the solution has been shown to
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be critical to ionizing and deprotonating the head group for better binding strength to the
particle.241 Furthermore, the presence of salts can impact binding strength especially in
the context of charged synthetic and biological ligands where charge screening can take
effect.242 Therefore, it would be prudent to investigate effects of solution pH on binding
efficacy of various and commonly utilized head groups. It would be particularly
interesting to study the changes in extent of ligand exchange with solutions of caffeic
acid or other catechols at varying pH values. Caffeic acid is prone to oxidation and is
sensitive to pH changes.243 Additionally, introduction of salts in particle solutions could
be explored to determine the effects on binding and dissociation of the ligands. This
would be useful to investigate changes in ligand exchange with charged ligands like
zwitterionic dopamine sulfonate. Isothermal titration calorimetry (ITC) could be used to
determine binding affinities under these variable conditions. Control of these variables
can directly impact the practical applications of these materials.
Ligand exchange and ligand binding are governed by thermodynamics. Therefore, it
follows that temperature has an impact on these processes.238 Increased temperatures can
have a positive impact on exchange especially in the case of diffusion limited
reactions.244 Study of this factor is intriguing as it pertains to the use of iron oxide
nanoparticles for magnetic hyperthermia. The particles are exposed to an alternating
magnetic field which results in elevation of the temperature (Figure 6.1). Quantitative
measurement of ligand coverage before and after exposure to an alternating magnetic
field could allow for the understanding of bulk and local heating effects on ligand
desorption and stability of the particles. Additionally, this study could be performed with
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the particles suspended in biological media or buffers to observe any competitive
binding. ITC measurements could also be used to probe thermodynamics of ligand
exchange at different temperatures.

Figure 6.1. Exposure of sample to alternating magnetic field through copper coil. Setup
for measuring specific absorption rate.

Ligands of increased chain length have been shown to bind more robustly and improve
stability of particles via steric stabilization.245, 246 Furthermore, increased length has been
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shown to increase acidity of the binding group and thus, the binding strength.247
Correlation of this factor with particle size would be a worthwhile investigation for
optimization of polymer-particle systems for a variety of applications. Tail group
chemistry has also been shown to affect ligand exchange rates depending on the
electronic properties of the substituents.239, 248 Therefore, kinetic and thermodynamic
studies of exchange with polymeric ligands with the same binding group but different tail
groups could allow for greater understanding of this phenomena.
6.2 Radiolabeled Polymers
Polymers are attractive for surface modification of nanomaterials due to the ability to
tailor molecular weight and end group chemistries. Synthesis of radiolabeled polymers
could improve feasibility of studying the aforementioned factors. This would allow for
direct measurement of adsorption of the desired ligand to the surface of the particles.
Furthermore, the polymers could be synthesized with specialty chemistries to investigate
binding group chemistry, tail group chemistry, and multidenticity. These properties are
also desirable for modification of other materials such as drugs and other biological
moieties. Conjugation of poly(ethylene glycol) (PEGylation) to drugs is common
practice and requires polymers with reactive end groups.77, 135 Radiolabeling of the
polymers allows for detection of the drug vehicle and, depending of the mechanism of
delivery, the drug itself for biodistribution studies.249, 250
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Synthesis of 14C-labeled PEG can be achieved either through end group modification of
the polymer with a radiolabeled molecule or via synthesis of the polymer with a
radiolabeled initiator so that the polymer backbone is inherently labeled. The first
synthetic technique has been done using 14C-succinic anhydride to modify PEG and allow
for conjugation to doxorubicin. This is described in greater detail in Appendix A.
Synthesis of inherently labeled polymer may be achieved via anionic, ring-opening
polymerization of ethylene oxide using a radiolabeled initiator. An example of this is
shown in Figure 6.2.

Figure 6.2. Synthesis of radiolabeled PEG via anionic ROP of ethylene oxide with 14Clabeled potassium methoxide.
This method could be used to synthesize polymers which are monofunctional or
difunctional for further reaction with drugs and other biological molecules. Furthermore,
LSC is a sensitive technique which allows for the use of low activities. Synthesis and use
of these materials grants many possibilities for expansion of this research.
6.3 Colloidal Stability Studies
Ligands do not only provide functionalization and impart solubility to nanomaterials but
must also provide good colloidal stability for successful application. Colloidal stability is
often observed through DLS measurements. Inclusion of colloidal stability
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measurements is necessary to fully understand the ability of the ligands to perform as
designed. Furthermore, colloidal stability measurements can be used to interpret particle
behaviors due to charge interactions and steric and/or charge stabilization in application
relevant environments. Observation of stability of the aged particles throughout the
ligand exchange reaction or afterwards could illuminate mechanisms of action which
resulted in the observed extents and rates of ligand exchange. Aging of the particles
resulted in diminished magnetic response which contributes to the overall stability of the
particles in solution. Changes in magnetic attractions of the particles could result in
flocculation of the particles and thus, changes in the ability of ligands to reach the surface
of the particles.
6.4 Other Metal and Metal Oxide Nanoparticles
This work has focused on surface modification of iron oxide nanoparticles, but the
techniques developed in this work can be applied to other types of metal and metal oxide
nanoparticles. Changes in the composition of the particles mean changes in the head
groups which will bind to the particles. Substituted metal ferrites like cobalt and
manganese ferrites have attracted interest due to the ability to tune the magnetic, electric,
and catalytic properties by controlled introduction of metal ions into the lattice of the
particles.251 Determining a binding hierarchy of head groups for these types of particles
and observing changes due to metal substitution would be of interest for progressing this
research forward. Furthermore, use of other metal and metal oxide materials could
present opportunities to include other radioisotopes for single or even dual-labeled
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measurements. For example, phosphonates have been shown to bind well to titanium
oxides.252

32

P could be used to label ligands for quantification of exchange with other

ligands, possibly 14C-labeled ligands. Dual-labelling could improve the accuracy of
detection advance our knowledge of these complexes.
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APPENDIX A
The material in Appendix A was taken from a Clemson University Honors Thesis written
by Melanie Ghelardini on work performed by both of us.
RADIOLABELING OF POLYMER-DRUG CONJUGATES FOR EASIER
QUANTITATIVE CHARACTERIZATION IN VIVO
Introduction
Polyethylene glycol (PEG) is commonly utilized in drug delivery systems as result of its
tunable properties and its safety profile for biological use.253 This is done through a process
known as PEGylation wherein polyethylene glycol is covalently attached to proteins or
drugs, as a means to reduce immunogenicity and extend their circulation time in the
body.254 For example, there is the PEGylated protein Adagen®, which serves as an
alternative to bone marrow transplants for patients suffering from severe combined
immunodeficiency disease (SCID). It acts as an enzyme replacement therapy for the
missing adenosine deaminase (ADA) for those suffering from SCID.255 There are also
PEGylated small molecules drugs such as Prothecan®, which is PEGylated in order to
improve water solubility and in vivo drug circulation time, as campothecin has poor water
solubility and is physiologically unstable.255
Attachment of PEG is beneficial as it increases the size of the drug molecule, reducing
kidney filtration. This size increase is based upon the fact that every ethylene glycol unit
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is associated with at least two water molecules, making them five to ten times larger than
a protein of similar mass.256, 257 PEGylation increases biocompatibility, solubility, and
hydrophilicity characteristics of the molecule or drug, and protects against recognition and
digestion from antibodies.254 PEGylation can be further utilized by bonding branched
chains at specific points along the molecule to release PEG when exposed to specific
outside stimuli, allowing for de-PEGylation and the release of the drug molecule.254
PEGylation also reduces the cytotoxicity of the drug, results in less leakage, and reduces
immunogenicity.258, 259 Additionally the longer PEG chains used in PEGylation are not
subjected to metabolism. Depending on the molecular weight they are eliminated from the
body in two ways. PEG with a molecular weight smaller than 20kDa is removed through
the kidneys, while those greater than 50kDa are removed through the liver. Generally renal
elimination decreases with increasing PEG size, so larger PEGs will be more likely
eliminated through the liver.260
The PEGylation process has undergone several advancements since its inception as a drug
delivery and targeting mechanism. The original, first generation of PEGylated molecules
resulted in a target molecule which was nonspecifically and permanently linked to linear
PEG chains.254

This resulted in the formation of multiple isoforms with varying

physiochemical and pharmaceutical features.257 The following, second generation resulted
in a molecule which was PEGylated through the addition of branched chains at specific
points along the molecule’s backbone. This would enable the PEG to be released as a
response to outside stimuli.254 It further decreases the amount of impurities and the side
products that occur during the PEGylation process. Additionally, the introduction of
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branched PEG decreases the molecule’s immunogenicity and increases half-life in
comparison with the first generation PEGylated molecule.

This second generation,

branched PEG addition unfortunately reduces the activity of the biomolecules attached to
the PEG.257 A third generation of PEGylated biomolecules are currently being researched
which do not limit the activity of the biomolecules. This would aim to minimize the tradeoff between the strength of the drug and the circulation time, as is the case in second
generation PEGylated drugs. Several techniques exist to do this, such as using releasable
PEG conjugates as a prodrug approach. Another technique creates customized PEGylation
sites on the protein or drug, reducing steric hindrance.257 As of 2011, eleven PEGylated
drugs were FDA approved for use.254 In 2015 an additional three PEGylated drugs were
approved and available on the market, with over twenty more PEGylated drugs in the
process of conducting clinical trials.257 As a result of recent innovations, PEGylated drugs
are potentially a multi-billion dollar market.257 This financial outlook, and the beneficial
characteristics imparted to a drug through PEG addition, exemplifies the viability of
PEGylation and the use of polyethylene glycol in the medical industry.
The polymer-drug conjugate synthesized must be analyzed to ensure its efficacy prior to
use. It must be verified that the PEGylated drug is biocompatible and nontoxic to the
subject. It is further necessary to know the fate of the PEGylated compound in the subject’s
body, and also in what quantities and what organs it concentrates. This is done through
biodistribution studies, which are designed to inform the need of additional preclinical
studies.261 It is additionally necessary to meet standards of homogeneity, pyrogenicity, and
to verify that the activation and coupling techniques are reproducible.256 Current methods
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of biodistribution analysis and quantification have limitations in their effectiveness and in
their accuracy. One such method involves the addition of a fluorescent dye such as the NIR
fluorophores Cy5,5 and Cy7 as a method of tracking the PEGylated biomolecules in the
subject.262, 263 Similar attachment and optical tracking can be completed through the use
of quantum dots.264, 265 Modification with the dye molecule or quantum dots enables the
non-invasive, qualitative visualization of the location of the biomolecule through the use
of a non-invasive near infrared fluorescence imaging system (NIRF).

This further

facilitates the creation of an approximate time dependent excretion profile by showing the
total NIRF intensity per region in the body, calculated as a function of time.263 However,
modification with a dye molecule or quantum can alter the chemistry and limit the
functionalization of the polymer, so other methods of analysis should be considered.
Another method of analyzing the PEGylation and the biodistribution of PEGylated drugs
is through a radiolabeling process.249,

250, 266-268

Labeling with radioisotopes is

advantageous because they are high in sensitivity and easily detectable, allowing for easy
visualization, traceability, and quantification.269 In this method, a radiolabeled component
is attached to the polymer-drug conjugate, acting as a tracker.

These radiolabeled

components enable the use of liquid scintillation counting (LSC) and positron emission
tomography (PET) imaging to qualitatively and quantitatively analyze the activity, and thus
the amount of polymer-drug conjugate in the body. It also provides information regarding
which organs contain the polymer-drug conjugate in the greatest quantities. Commonly
utilized radiolabeled components are Indium-111, Copper-64, Hydrogen-3, Iodine-125,
etc.249, 250, 266-268 Similar to the usage of dyes and quantum dots to quantify and track PEG,
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the usage of radiolabeled trackers also has shortcomings. The attachment of the radiolabel
tracker requires the alteration of the of the polymer-drug conjugate, and has the capability
to alter the chemistry and limit functionalization of the system, as the radiolabeled
component must bind to a functional group present on the conjugate system.
One method which does not alter the chemistry of the polymer-drug complex is labelling
with carbon-14. Recent studies document use of this as a tracking mechanism.270-274
Carbon-14 maintains the integrity of the polymer drug conjugate, as radiolabeled carbon14 can simply be inserted along the backbone of the polymer chain, replacing ordinary
carbon-12 groups. As a result, none of the functionalization groups are altered or made
unavailable, as is the case in the other methodologies.269 This labeling with carbon-14 is
clearly beneficial in comparison with other methods, as it preserves molecular structure
through the lack of radiolabeled pendant groups, and produces few changes in chemical or
biological properties.269 This direct insertion along the backbone reduces the risk of label
cleavage and oxidation. Furthermore, there is a distinct isotopic signature peak present in
the mass spectra of the diluted carbon-14 compound, which is beneficial during analysis.269
Utilizing a drug or molecule that is inherently fluorescent is another option used in
studies. This is particularly true of the drug doxorubicin.272, 275, 276 Doxorubicin belongs
to a class of anthracycline drugs, which are often used to monitor the drug’s location
within the delivery system and as a means of assessing the drug’s interactions with DNA
and other macromolecules present in the system.277 This assessment is enabled by the
chemical structure of the amphiphilic drug, which contains a fluorescent hydroxy-
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substituted anthraquinone chromophore and a hydrophilic aminoglycosidic chain.277 As a
result of this structure, the doxorubicin is UV-Vis active and presents red fluorescence.278
By utilizing doxorubicin as the drug conjugate, a secondary dye component is not
required, because the fluorescence of doxorubicin is inherent. This lack of a dye pendant
group means that the chemical structure and thus the integrity of the polymer drug
conjugate is maintained and the chemical properties of the system are unaltered.
This study utilizes the beneficial characteristics of carbon-14 labeling and the fluorescent
characteristics of doxorubicin as a means of creating a novel tracking and analysis
method. It sensitively quantifies the fate and biodistribution of both the polymer and the
drug utilized when the conjugate is inserted into a biological system. PEG-methyl ether
polymer was modified with labeled succinic anhydride to create a PEG with an overall
activity of approximately 200 nCi. This methyl ether component was necessary as
previous research has shown that stable linkage between PEG requires either an active
carbonate, active ester, aldehyde or tresylate group for successful modification. This
reaction created a further carboxylic acid group, which was used in a secondary reaction
to attach the doxorubicin. Fourier transform infrared spectroscopy (FTIR) was utilized to
confirm the presence of the carboxylic acid group, while liquid scintillation counting
(LSC) was used to verify that the desired activity was produced. EDC chemistry was
then used to react the primary amine present on doxorubicin with the previously attached
carboxylic acid group on the PEG. The chemical components utilized to create this
polymer drug conjugate are shown as Figure A1. This compound was dialyzed and later
analyzed through FTIR, UV-Vis, and LSC to ensure attachment of the doxorubicin and
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that the activity of the sample remained in the desired range. This design is beneficial as
it potentially provides two different methods of tracking the polymer drug conjugate in a
biological system, through the radiolabeled carbon-14 and the fluorescent doxorubicin,
without altering the typical structure or properties of either component.

Figure A1. Reagents used for synthesis of 14C-labeled PEG-doxorubicin.

Experimental
Materials
Poly(ethylene glycol) (PEG) methyl ether (Mn 10,000 g/mol), N-hydroxysulfosuccinimide
sodium salt (sulfo-NHS) (98%), 4-dimethylaminopyridine (DMAP) (>99%), 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer solution (1 M, pH 7.3),
and succinic anhydride (>99%) were purchased from Sigma Aldrich. Doxorubicin
hydrochloride (>99%) was purchased from LC Laboratories.
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1-Ethyl-3-(3-

dimethylaminopropyl) carbodiimide (EDC) was purchased from TCI America. Succinic
anhydride (2,3-14C) was purchased from American Radiolabeled Chemicals. Optiphase
‘HISAFE’ 3 liquid scintillation cocktail was purchased from Perkin Elmer. Spectra/Por®
dialysis membranes (MWCO 1000 Da) were purchased from Spectrum Labs.
Tetrahydrofuran (THF; 99%) was purchased from BDH Chemicals.
Synthesis of radiolabeled carboxylic acid functionalized PEG
The first step in creating the polymer-drug conjugate was to form radiolabeled carbon-14
linkages along the backbone of the polymer.

This involves the modification of

polyethylene glycol (PEG) methyl ether of 10,000 g/mol molecular weight through the
addition of carbon-14 radiolabeled succinic anhydride, with a specific activity of
5mCi/mmol. THF was used as a solvent and DMAP was used as a catalyst to promote the
reaction. Relative to the PEG methyl ether, the DMAP and succinic anhydride were added
in a molar ratio 1.0:0.01:1.1. This resulted in the addition of 1.2 mg PEG (0.12 μmol), 0.16
µg DMAP (1.2 nanomoles), and 700 nCi of 14C-succinic anhydride (14 µg; 0.14 μmol) to
an Erlenmeyer flask. This reaction proceeds according to Figure A2, and results in the
formation of two radiolabeled carbon-14 groups along the chain and the creation of a
carboxylic acid group, which is necessary for the later attachment of doxorubicin. This
radiolabeled polymer was dried, transferred to water and purified through dialysis for use
in the next reaction. Dialysis tubing of a molecular weight cut-off of 1000g/mol was
utilized in this step, and the polymer was dialyzed for 48 hours. Only a small amount of

152

polymer was synthesized, so FTIR and LSC characterization were not completed at this
point.

Figure A2. Modification of PEG with labeled succinic anhydride.

PEGylation of doxorubicin
Doxorubicin was attached through EDC chemistry in an aqueous solution. Sulfo-NHS was
utilized in conjunction with EDC, in comparison with pure NHS, which is utilized when
THF is the solvent. The sulfo-NHS was added in a 1.0:1.2 molar ratio relative to the PEG
functionalized with the carboxylic acid, as was the EDC. After allowing this to react for
four hours, doxorubicin was added to the solution in a molar ratio of 1.0:1.5 relative to
PEG and doxorubicin. Roughly 1.2 mg (0.12 μmol) of the carboxylic acid functionalized
PEG was added to a flask, in conjunction with 31 µg (0.14 μmol) sulfo-NHS, 27 µg (0.14
μmol) EDC. This solution was allowed to react for four hours and then 98 µg (0.18 μmol)
doxorubicin was added. This two-step reaction proceeds according to Figure A3 and results
in the formation of the desired radiolabeled polymer drug conjugate. This component was
dialyzed in tubing with a molecular weight cutoff of 8000 g/mol in order to purify the
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compound.

LSC and UV-Vis were used to determine the activity and amount of

doxorubicin conjugated in the recovered sample.

Figure A3. PEGylation of doxorubicin with 14C-labeled PEG-succinic acid.

Synthesis of unlabeled PEG-doxorubicin
Unlabeled PEG-doxorubicin was synthesized separately and combined with the
radiolabeled material to control the final specific activity of the sample. The same
chemistry was used in this synthesis. For the first step, the attachment of the carboxylic
end group, 1.815 g (0.1815 mmol) of PEG methyl ether was added to THF. After this,
19.98 mg (0.200 mmol) of succinic anhydride was added to the same flask representing a
1.0:1.1 ratio between the PEG and the succinic anhydride. 0.2217 mg (1.815 μmol) of
DMAP was then added, indicating a 1.0:0.01 molar ratio once again. This compound
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was then purified through dialysis as described earlier and dehydrated through a freeze
dryer to revert it to a solid polymer rather than a liquid solution.
Attachment of the doxorubicin proceeded through the use of EDC chemistry as
previously described. 11.3 mg (1.12 μmol) of the carboxylic acid modified PEG was
added to an Erlenmeyer flask. After this sulfo-NHS was added in a ratio of 1.0:1.2
relative to the PEG, such that 0.261 mg (1.343 μmol) was added to the flask.
Subsequently, EDC was added in this same ratio relative to PEG, resulting in the addition
of 0.208 mg EDC (1.343 μmol). This reaction was allowed to run for four hours prior to
adding doxorubicin in a 1.0:1.5 ratio relative to the PEG functionalized with carboxylic
acid. This ratio resulted in the addition of 0.912 mg (1.678 μmol) doxorubicin to the
Erlenmeyer flask. After allowing the system to react, the compound was purified through
dialysis, after which it was combined in an aqueous mixture with the previously
radiolabeled components. This was done by adding the radiolabeled polymer with the
unlabeled polymer in an aqueous solution and agitating it. The final polymer-drug
conjugate was characterized for future use in a biodistribution study.
Characterization
Several methods of characterization were completed to confirm that the polymer-drug
conjugate was properly prepared and had the appropriate chemistry for its end use. The
first test completed was FTIR, verifying that the desired chemistry was present. A
droplet of the polymer-drug conjugate was placed onto the sample plate and analyzed
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through use of the Thermo Scientific Nicolet 6700. By utilizing FTIR it was possible to
determine that the structure contained the appropriate peaks, and thus that the desired
ether group, aromatic alkene group, and the carbonyl group were present in the final
conjugate. This was the first step in verifying the product created through the synthesis
steps was representative of the desired conjugate.
After completing FTIR to determine the chemistry of the synthesized product, the
presence and concentration of doxorubicin was doubly verified through the use of UVVis spectroscopy. UV-Vis determines the compound’s valence electrons, in both its
excited and ground states. A small sample was examined through the use of a Varian
Cary 50 Bio UV-Visible Spectrophotometer. The sample has a distinctive absorbance
value, which can be used to calculate the concentration of doxorubicin present in the
sample. This is done by comparing the sample’s absorbance with a calibration curve
created from samples of known doxorubicin concentration. The is a beneficial form of
analysis, as it not only verifies the presence of doxorubicin, but also the concentration of
the doxorubicin present in the polymer-drug conjugate. This is useful for the dosage
determination in the biodistribution study.
The final method of analysis involved the calculation of the sample’s activity through
LSC calculations. A few microliters of sample were added to a vial containing 7 mL of
LSC cocktail and input into the Perkin Elmer TriCarb 2910TR machinery for analysis.
This machinery provides information regarding the number decays per minute, which can
be converted into a representation of activity per milliliter. This was beneficial as it
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verified that the activity of the sample was within the desired 100 nCi range for detection
within the biological system. After completing these characterization methods, the
sample was then deemed ready for use in the biological subject in the biodistribution
study.
Results and Discussion
Several characterization techniques were completed during the synthesis of the polymerdrug conjugate, namely UV-Vis, LSC, and FTIR. FTIR was completed on the unlabeled
carboxylic acid functionalized PEG, and on the final product of the combined
radiolabeled/unlabeled PEG-Dox conjugate. LSC was completed on the radiolabeled
polymer-drug conjugate to verify the radionuclide identity and for calculation of its
activity. Finally, UV-Vis was used to determine the success of the dialysis procedure,
and in the calculations which determined the combining procedure of the labeled and
unlabeled polymer-drug conjugates.
As stated previously, the first method of characterization completed was FTIR. After
completing the first modification with the unlabeled succinic anhydride, the success of the
modification was determined through FTIR. This was not completed for the radiolabeled
carboxylic acid functionalized PEG as a result of the small volume of sample created. The
spectra gathered for the unlabeled component served as a comparative, representative
spectra for the radiolabeled component. The results of this analysis are shown in Figure
A4. The peak around 1114 cm-1 represents the ether linkage of CH2-O-CH2 in the polymer
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chain backbone, while the peak around 1722 cm-1 represents the carbonyl C=O pendant
group. The peak present around 2900 cm-1 is indicative of background substances or
unreacted components of the reaction, and is not vital for further analysis. This FTIR
visualized the success of the reaction, and allowed for the next step, the attachment of
doxorubicin to be completed.

Figure A4. FTIR of PEG-succinic acid.

After completing the attachment of doxorubicin for both the radiolabeled and unlabeled
carboxylic acid functionalized PEG, and the subsequent combination of the two
components, additional FTIR was completed. It had a very similar spectrum as the one
previously conducted for the carboxylic acid modified PEG, with an additional peak
indicating the presence of aromatic alkene groups. This is shown in Figure A5 below.
The relevant peaks for verification of the presence of doxorubicin and the polymer
backbone are depicted at 1114 cm-1, 1774 cm-1, and in the range of 1490-1526 cm-1.
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Once again the peak near 1114 cm-1 is representative of the ether linkage of the polymer
backbone, while the 1722 cm-1 peak represents the carbonyl pendant group along the
backbone. Finally, the new peak in the range of 1490-1526 cm-1 shows the presence of
the aromatic rings in doxorubicin as it indicates an aromatic alkene group. These FTIR
results provided verification that the drug-conjugate was synthesized, without providing
any information regarding the activity or concentration of doxorubicin present in the
system. Further analysis through LSC and UV-VIS were required to gain this
information.

Figure A5. FTIR of the final polymer-drug conjugate (unlabeled and labeled combined).

LSC was utilized to provide information regarding the activity of the final radiolabeled
polymer-drug conjugate, prior to combination with the unlabeled radiolabeled polymer
drug conjugate. This was viewed through a graphical representation of energy in
kiloelectronvolts vs. counts, as shown in Figure A6. This provides qualitative
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information capable of identifying the radionuclide used. However, quantitative
information, in the form of counts per minute, was used to determine the activity of the
sample. This was done by utilizing the fact that the decays per minute can be calculated
through a relation between the counts per minute of the sample, the counts per minute of
the background, and the counting efficiency, as shown by the following equation:

Eq. A1) 𝑑𝑝𝑚 =

𝑐𝑝𝑚 𝑠𝑎𝑚𝑝𝑙𝑒−𝑐𝑝𝑚 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑
𝑐𝑜𝑢𝑛𝑡𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦

.

where dpm is decays per minute, cpm is counts per minute and counting efficiency of 14C
is determined by counting a 14C standard.

Figure A6. LSC spectrum of final polymer-drug conjugate.

In this instance, the counts per minute of the sample was 1065, while the background
sample was 17 counts per minute, and the count efficiency was 0.931. The decays per
minute of the sample is about 1125, which can be divided by the volume of the LSC
sample (0.03 ml) to obtain 37,522 dpm/ml. This number can be multiplied by the total
volume of polymer solution (19.4 ml) to obtain a total dpm of 727,934. Finally, this can
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then be converted into nanoCuries (nCi) of sample activity based around the fact that 1
nanoCurie is equivalent to 2200 decays per minute. Utilizing this conversion shows that
the sample of the polymer was roughly 330 nCi in activity. Some of the initial activity
was lost during the transfer of the product from the dialysis tubing after the first and
second modification steps for the radiolabeled synthesis. Regardless of this loss, the 330
nCi activity still provided flexibility when combining the labeled and unlabeled
components of the polymer-drug conjugate, as the goal was a specific activity of 200
nCi/mg of dox-equivalent. By combining the labeled and unlabeled polymer-drug
conjugate according to the concentration of doxorubicin, it was possible to roughly create
this desired specific activity of the polymer-drug conjugate.
UV-Vis was used to determine the concentration of doxorubicin in the final product. A
series of standards for doxorubicin was created over varying concentrations to create a
calibration curve. The concentration values utilized to calculate this were as follows:
0.04998 mg/ml, 0.009966 mg/ml, 0.004994 mg/ml, and 0.000994 mg/ml. The
absorbance value for the corresponding wavelength of doxorubicin, 483 nm, was
recorded for each of these concentrations and then plotted to create said calibration curve.
The PEGylated samples were measured and the absorbance values at 483 nm were
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compared to the calibration curve to determine the concentrations of the samples. This is
shown in Figures A7 and A8.

Figure A7. UV-Vis spectra of standards and PEGylated doxorubicin samples.

Figure A8. UV-Vis calibration curve.
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To achieve a specific activity of 200nCi/mg of dox equivalent, roughly 100 nCi of the
radiolabeled polymer was used. The specific activity of the succinic anhydride is 5000
µCi/mmol. Using this specific activity, the activity of the polymer, and the molecular
weight of doxorubicin it was determined that 100 nCi of the radiolabeled polymer-drug
conjugate should contain approximately 0.0108 mg of doxorubicin. This value agrees
closely with the total concentration determined by UV-Vis. To reach the desired specific
activity, approximately 0.48 mg of unlabeled polymer-drug conjugate was added. The
final specific activity of the sample was 204 nCi/mg of dox-equivalent.
Conclusions

This study was designed to create a novel tracking system for biodistribution studies.
This consisted of a polymer-drug conjugate which provided qualitative and quantitative
data regarding its location in the body and where it concentrates. Furthermore, the
accuracy was ensured using a two-part tracking system, as doxorubicin’s fluorescent
characteristics enable UV-Vis analysis, while the radiolabeled polymer can be tracked
through LSC analysis.
In order to create such a polymer-drug conjugate, a multiple step synthesis procedure was
followed, for both radiolabeled and unlabeled components. First PEG-methyl ether was
modified with labeled or unlabeled succinic anhydride to create a carboxylic acid
functionalized group. This carboxylic acid group was capable of reacting with
doxorubicin through EDC chemistry to create the desired polymer-drug conjugate. The
labeled and unlabeled components were the combined in specific ratios relative to one
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another to create a final product with an activity of roughly 200 nCi. During this
procedure, several methods of analysis were completed to ensure that the synthesis was
proceeding appropriately.

FTIR was utilized to ensure that the desired reactions had occurred by analyzing the
observed peaks for the presence of specific functional groups. After verifying that the
reactions proceeded appropriately for both the labeled and unlabeled reactions, LSC was
completed to determine the activity of the individual labeled polymer-doxorubicin
component. This was necessary for the later combination with the unlabeled polymerdoxorubicin component. UV-Vis served as another method of ensuring that doxorubicin
was present, as its fluorescence was observed at 483 nm. Furthermore, by creating a
calibration curve, the concentration of both the labeled and unlabeled components could
be determined. This information enabled the combination of the two systems in specific
ratios to create a final polymer-drug conjugate of roughly the desired activity.
Ultimately, this study verified that the synthesis of a potential two-part tracking system
was possible through the combination of a radiolabeled polymer-backbone and a
fluorescent-active drug conjugate. It further showed the viability of FTIR as a means of
ensuring occurrence of reaction, LSC to determine the activity of such a system, and UVVis to determine the concentration of doxorubicin in the polymer drug conjugate. This
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system is nearly ready for use in a biodistribution study to confirm efficacy of drug
delivery and utility of this method for detection of distribution.
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